European Curriculum Vitae · 2018-11-26 · 1 European Curriculum Vitae Personal information First...
40
1 European Curriculum Vitae Personal information First name / Surname Date of birth Gender Nationality Language Work Address Claudio Cerchione, MD, PhD 19/02/1984 M Italian Italian (native tongue), English, German, Spanish Hematology Unit, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Via Piero Maroncelli 40, 47014, Meldola (FC), Italy Personal Address Viale Augusto 140, 80125, Naples, Italy Personal E-mail Membership [email protected] ASH (American Society of Hematology) EHA (European Society of Hematology) SOHO (Society of Hematologic Oncology) SIE (Società Italiana di Ematologia) SIES (Società Italiana di Ematologia Sperimentale) AIL (Associazione Italiana contro le Leucemie, Linfomi, Mielomi) AIEOP (Associazione Italiana di Ematologia e Oncologia Pediatrica) ACLTI (Associazione contro le Leucemie e i Tumori dell’Infanzia) Rotary Club
Transcript of European Curriculum Vitae · 2018-11-26 · 1 European Curriculum Vitae Personal information First...
1
European
Curriculum Vitae
Personal information
First name / Surname
Date of birth
Gender
Nationality
Language
Work Address
Claudio Cerchione, MD, PhD
19/02/1984
M
Italian Italian (native tongue), English, German, Spanish
Hematology Unit, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Via Piero Maroncelli 40, 47014, Meldola (FC), Italy
Personal Address
Viale Augusto 140, 80125, Naples, Italy
Personal E-mail
Membership
ASH (American Society of Hematology) EHA (European Society of Hematology) SOHO (Society of Hematologic Oncology) SIE (Società Italiana di Ematologia) SIES (Società Italiana di Ematologia Sperimentale) AIL (Associazione Italiana contro le Leucemie, Linfomi, Mielomi) AIEOP (Associazione Italiana di Ematologia e Oncologia Pediatrica) ACLTI (Associazione contro le Leucemie e i Tumori dell’Infanzia) Rotary Club
2
Degree
Professional Medical Qualification
Residency
PhD program
European Hematology Exam
AIL
Volunteer Membership
Emergency Medical Service
Experience as Specialist
Membership - details
Degree in Medicine, University Federico II, Napoli, Italy, 110 cum laude, July 2008 (Final thesis in Hematology–New TKI in CML)
270/270, February 2009, School of Medicine – University Federico II, Naples, Italy
Hematology, 50 cum laude, July 2014, University Federico II, Naples, Italy Italy (Final Thesis in Myelodysplastic Syndromes) Newer biomedical and Surgical treatments, Department of Clinical Medicine and Surgery - University Federico II, Naples, Italy (Tutor prof Fabrizio Pane - Director prof Giovanni Di Minno) Ottimo cum laude, May 2017, University Federico II, Naples, Italy Italy (Final Thesis in Multiple Myeloma)
European Hematology Exam (EHA - European Society of Hematology), 12 June 2018
Home care doctor in Adult Hematology (since November 2014) Home care doctor in Pediatric Hematology (since May 2015)
Scientific Responsible of ACLTI (Associazione contro le Leucemie e i Tumori dell’Infanzia)
ASL Napoli 1 (also Secondigliano Jail, Naples) since September 2011
Pediatric OncoHematology A.O.R.N. Santobono-Pausilipon Hospital since July 2014
1) AIL (Associazione Italiana contro Leucemie-Linfomi-Mielomi) since 2009
2) SIE (Società Italiana di Ematologia) since 2009 3) SIES (Società Italiana di Ematologia Sperimentale) since 2016 4) EHA (European Hematology Association) since 2009 5) AIEOP (Associazione Italiana Ematologia Oncologia Pediatrica)
since 2015 6) SOHO (Society of Hematologic Oncology) since 2017 7) ASH (American Society of Hematology) since 2017 8) ACLTI (Associazione contro le Leucemie e I Tumori dell’Infanzia) –
Scientific Responsible – since 2017 9) Rotary Club – since 2017
Work experiences
September 2018
3
September 2018 – Today
September 2018 – Today
May 2018 – Today
Sep 2017 - Today
Winner of Clinical Research Training in Hematology (CRTH) – European Hematology Association (EHA) 2018/2019
“Dirigente Medico” in Hematology – IRST IRCCS Meldola (FC) – Italy
Scientific Projects in Pediatric OncoHematology (Supervision Dott. M. Ripaldi), OncoHematology Department, A.O.R.N. Santobono-Pausilipon, Naples, Italy.
Scientific Projects in Hematological Malignancies (Supervision Prof. F. Pane), Hematology Division, Department of Clinical Medicine and Surgery, University “Federico II”, Naples, Italy. Scientific Projects in Hematological Malignancies (Supervision Prof. F. Ferrara), Hematology Division, A.O.R.N. Cardarelli, Naples, Italy.
September 2014 – Aug 2018
July 2014 – Aug 2018
In charge for Clinical management of Multiple Myeloma/MGUS (Supervision Prof. F. Pane), Hematology Division, Department of Clinical Medicine and Surgery, University “Federico II”, Naples, Italy. Pediatric OncoHematology, Santobono-Pausilipon Hospital, Naples, Italy
July 2009 – July 2014 Residency in Hematology, Hematology Division, Department of Clinical Medicine and Surgery, University “Federico II”, Naples, Italy. - Clinical management of Chronic Myeloid Leukemia, Anemia and
Myelodysplastic syndromes, Lymphoproliferalive disorders (particularly non-Hodgkin and Hodgkin Disease and CLL), Pediatric Oncohematology, Multiple Myeloma and Ph- Myeloproliferative neoplasm, Autologous and Allogenic Bone Marrow Transplantation.
Sep 2006 – June 2009
Sep 2008 – Oct 2008
Sep 2005 – Sep 2006
Sep 2002 – July 2008
September 1997 – June 2002
Visitor Student, Hematology Division, University of Naples “Federico II”, Italy. Visitor Medical Student (Clinical Clerkship) – Research and clinical activities in Hematology Department, Hospitais da Universidade de Coimbra (Director prof Adriana Teixeira), Portugal Visitor Medical Student (Erasmus project) – Research and clinical activities in Hematology Department, Friedrich-Wilhelms Universitat Bonn (Director prof Schmidt Wolf), Germany Medical Graduation, School of Medicine “Federico II”, Italy High school Graduation, Scientific Lyceum “N. Copernico”, Naples, Italy (Final mark 100/100)
4
Fields of interest and research - Clinical management and research on Multiple Myeloma and MGUS, with particular interest in imaging diagnostic techniques, alternative chemotherapy regimens in relapsed/refractory patients and transplantation procedures.
- Clinical management and research on Chronic Myeloid Leukemia and Ph- Myeloproliferative neoplasms, with research interest on mechanisms of second generation TKIs.
- Clinical management and research of Myelodysplastic Syndromes and Acute Leukemias, with particular interest on role of demethylating agents.
- Clinical management and research of Hodgkin and non-Hodgkin Lymphomas and Chronic Lymphocytic Leukemia
- Clinical management and research of Pediatric Acute Leukemias - Clinical management and research of Infections in Hematologic patients,
with particular interest in diagnostic tools and imaging techniques, especially for invasive fungal infections
- Clinical management and research of Myelodysplastic Syndromes and Acute Leukemias, with particular interest on role of demethylating agents.
- Clinical management and research of Autologous and Allogenic Bone Marrow Transplantation (JACIE Certificate)
Education and training
1 April 2014 Ph.D. attendant, Hematology Division, University of Naples, Italy.
30 June 2009 Residency in Hematology, University of Naples, Italy, with full marks.
22 July 2002 M.D., University of Naples, Italy, with full marks.
Personal skills and competences
Native Speaking Italian
Other language English (Certificate C1.2 British Council, Naples, Italy)
Understanding Speaking Writing
Excellent Excellent Excellent
German (Certificate B2, Rheinische Friedrich-Wilhelms Universitat, Bonn, Germany)
Understanding Speaking Writing
Very Good Very Good Very Good
Personal skills and competences
5
BLSD (Basic Life Support early Defibrillation) (17/07/2010) AOU Federico II – Napoli - Italy P.T.C. (Pre-Hospital Trauma Care) (18/09/2010) AOU Federico II – Napoli - Italy BLSD (Basic Life Support Early Defibrillation) (20/09/2018) IRST – IRCCS – Meldola (FC) – Italy Teaching
Computer skills and
competences
Excellent knowledge of Office packages (Word, Excel, Power-point), Internet Explorer, Google Chrome, Mozilla Firefox and E-mail client (Outlook express), Operating systems (Microsoft Windows and Mac OS) User of statistical program (STAT v7, SPSS).
Driving licence European Driving license, type B
6
Research Teaching Assistant (“Cultore della materia”) in Hematology - University Federico II, Naples, Italy
1) Medicine and Surgery 2) Biotechnology 3) Laboratory techicians 4) Radiology technicians
Research Teaching Assistant in University Federico II, Naples, Italy 1) Training a field force – Teacher for AMGEN Staff (Santa Margherita di Pula (Cagliari), Italy)
Advisory Board/Consultant 1) Member of Carfilzomib International Advisory Board (AMGEN) 2) Member of “La nuova era degli anticorpi monoclonali nel trattamento del Mieloma Multiplo” – Advisory
Board (Janssen/EDRA) 3) FAD Course n. 158239 – Leucemia Mieloide Cronica dalla diagnosi al trattamento (BMS/EUBEA) 4) Experience sharing in Multiple Myeloma (BMS/Dynamicom)
Member of Scientific Committee 1) EUBEA, Naples, Italy
International and National Awards
1) Winner of Clinical Resarch Training in Hematology (European Society of Hematology) 2018/2019
2) Travel Grant winner at the 8th Stem Cell Course- Collegio Ghislieri, Pavia 3) Travel Grant winner at the 9th Stem Cell Course- Collegio Ghislieri, Pavia 4) Travel Grant winner at the 10th Stem Cell Course- Collegio Ghislieri, Pavia 5) Travel Grant winner at the 11th Stem Cell Course- Collegio Ghislieri, Pavia 6) Travel Grant winner at the 12th Stem Cell Course- Collegio Ghislieri, Pavia 7) Travel Grant winner at the 13th Stem Cell Course- Collegio Ghislieri, Pavia 8) iAcademy Award 2013 – Napoli 9) Travel Grant winner at Brain training in Hematology: Casi clinici stimolanti e allocuzioni lungimiranti
2013 (Italian Society of Hematology, Pesaro, Italy) 10) iAcademy Award 2014 – Napoli 11) Travel Grant winner at Corso Innovazioni in Ematologia 2014 (Italian Society of Hematology, Pesaro,
Italy) 12) Winner of Progressi in Ematologia – I giovani come protagonisti - SIE Giovani (Stazione Marittima,
Napoli) 13) Travel Grant winner at the 15th Stem Cell Course- Collegio Ghislieri, Pavia 14) Travel Grant winner at Ematologia nel 2015: come sta cambiando la musica (Italian Society of
Hematology, Pesaro, Italy) 15) Travel Grant winner at SIES (Società Italiana Ematologia Sperimentale) congress 2016, Rimini 16) Travel Grant winner at Nuovo Cinema in Ematologia 2016 (Italian Society of Hematology, Pesaro,
Italy) 17) Travel Grant winner at Novità in Ematologia, Modena, Italy 18) Travel Grant winner (with Oral Comunication) at EHA 2017, Madrid 19) Travel Grant winner at SOHO 2017, Houston, Texas, USA 20) Travel Grant winner at Springer Rising Medical Stars – High Formation Program, Milan, Italy 21) Rotary Club Volunteer prize 2018 22) Travel Grant winner at SOHO 2018, Houston, Texas, USA 23) Travel Grant winner at SIES (Società Italiana Ematologia Sperimentale) congress 2018, Rimini
Editorial Board Membership
7
1) Turkish Journal of Hematology 2) Jacobs Journal of Hematology 3) Academicians’Research Center Journal of Hematology (AJH) 4) Journal of Hematology and Clinical Research 5) Journal of Blood Disorders and Therapy / Journal of Applied Hematology and Blood Transfusion 6) Jorunal of Hematology and Multiple Myeloma 7) Global Journal of Infectious Diseases and Clinical Research 8) Annals of Bone Marrow Research 9) Austin Hematology 10) International Journal of Pharmaceutical Sciences and Developmental Research 11) International Journal of Aquaculture and Fishery Sciences 12) Annals of Antivirals and Antiretrovirals 13) The Journal of cancer prevention 14) The Journal of Pharmacology and Toxicology 15) Asclepius Medical Research and Reviews 16) Journal of Infection and Antibiotics 17) Journal of Infection Immunity and Vaccines 18) Journal of Cancer and Metastasis Research 19) Annals of Medical Case Reports 20) SM Journal of Carcinogenesis and Mutagenesis 21) SM Journal of Hematology and Multiple Myeloma 22) Infections and Treatment Journal 23) SM Blood Disorders and Transfusions 24) Global Journal of Infectious Diseases and Clinical Research 25) Journal of Emerging and Rare Diseases 26) Archives of Blood Transfusion and Disorders 27) Journal of Hematology and Clinical Research 28) Open Access Journal of Pediatrics and Neonatology 29) Journal of Cancer Metastasis and Treatment 30) Med One 31) International Journal of Cancer Research and Molecular Mechanisms 32) SRL Blood Disorders 33) Journal of Blood and Lymph 34) Annals of Blood Research 35) Open Access Blood Research and Transfusion Journal 36) Epigenetic Diagnosis and Therapy
Reviewer in journals:
8
1) PlosOne 2) BMC Cancer 3) Turkish Journal of Hematology 4) Future Oncology 5) Current Medical Research and Opinion 6) Annals of Clinical Cytology and Pathology 7) World Journal of Methodology 8) World Journal of Orthopedics 9) World Journal of Gastroenterology Pharmacology and Therapeutics 10) Hematology 11) World Journal of Hematology 12) Journal of Blood Disorders and Therapy / Journal of Applied Hematology and Blood Transfusion 13) Journal of Muskoloskeletal Disorders and Treatment 14) Archives of Blood Transfusion and Disorders 15) SM Hematology and Multiple Myeloma 16) International Journal of Orthopedics 17) Heighpubs Otolaryngology and Rhinology 18) Annals of Hematology and Oncology 19) International Journal of Cancer Reserach and Molecular Mechanisms 20) Journal of Infectious Diseases and Epidemiology 21) World Journal of Surgical Oncology 22) Annals of Bone Marrow Research 23) Journal of Hematology and Clinical Research 24) World Journal of Critical Care Medicine 25) British Journal of Pharmaceutical Research 26) Austin Hematology 27) Medical Science Monitor 28) Open Journal of Internal Medicine
Oral presentations national and international events:
1) Successful pregnancies in Chronic Myeloid Leukaemia male patient on Imatinib therapy
9
Annual meeting of “Centri di Ematologia Meridionale ed Insulare” (SIE SUD), 28-29 October 2010, Castellaneta Marina (Taranto, Italy)
2) Renal failure associated to tyrosine kinase inhibitors Annual meeting of “Centri di Ematologia Meridionale ed Insulare” (SIE SUD), 28-29 October 2010, Castellaneta Marina (Taranto, Italy)
3) Monitoraggio dei livelli plasmatici degli antimicotici azolici nei pazienti neutropenici e correlazioni con efficacia terapeutica ed effetti tossici Under40 Project in Hematology, 15-16 November 2012, Napoli, Italy
4) Terapia combinata con voriconazolo e caspofungina: una nuova arma contro l’Aspergillosi invasive iAcademy Award 2013 – 22 November 2013, Napoli, Italy
5) Ruolo della Bendamustina nel paziente con Mieloma Multiplo Recidivato e Refrattario Policlinico AOU Federico II – 3 April 2014, Napoli, Italy
6) Analisi della risposta agli agenti eritrostimolanti in una coorte di pazienti affetti da syndrome mielodisplastica low-risk afferenti al Registro Campano per le MDS Italian Red Cell Club 2014 – 3-4 October 2014, San Marcellino e Festo – Napoli, Italy
7) Efficacia del Voriconazolo nell’aspergillosi refrattaria alla terapia con amfotericina B : la nostra esperienza iAcademy Award 2014 – 27 November 2014, Avellino, Italy
8) Lo Sportello Giovani dell’Ordine dei Medici di Napoli incontra i Medici in Formazione 2014/2015 (2 March 2015, Policlinico Federico II, Napoli)
9) Mieloma Multiplo: Strategie a confronto: Switch: bilancio tra sostenibilità ed efficacia 23 April 2015, Hotel Royal – Napoli
10) Il mielodisplastico alto rischio: ruolo degli agenti ipometilanti La gestione delle alterazioni della crasi ematica e delle tossicità da chemioterapia: confronto tra esperti – II Edizione – 4 June 2015, Hotel Montespina, Napoli
11) Il mielodisplastico non trasfusione dipendente: ruolo dell’Epoietina La gestione delle alterazioni della crasi ematica e delle tossicità da chemioterapia: confronto tra esperti – II Edizione – 4 June 2015, Hotel Montespina, Napoli
12) Mieloma Multiplo – Winner of Progressi in Ematologia I giovani come Protagonisti - 4-5 marzo 2016, Napoli
13) Il Mieloma Multiplo: innovazioni nei trattamenti di prima linea e linee successive La gestione delle alterazioni della crasi ematica e delle tossicità da chemioterapia: confronto tra esperti – III Edizione – 16 June 2016, Hotel Montespina, Napoli
14) Il mielodisplastico non trasfusione dipendente: ruolo dell’Epoietina La gestione delle alterazioni della crasi ematica e delle tossicità da chemioterapia: confronto tra esperti – III Edizione – 16 June 2016, Hotel Montespina, Napoli
15) L’esperto risponde – Training a field force – Riunione di ciclo AMGEN 15 September 2016 - Fortevillage – Santa Margherita di Pula (Cagliari)
16) Mieloma Multiplo - Esperienze di pratica clinica: dalle opzioni terapeutiche alla strategia terapeutica Il Mieloma Multiplo - 5 May 2017, Hotel Royal, Napoli
17) Il trattamento del Mieloma Multiplo recidivato-refrattario Il valore dell’immuno-oncologia nel Mieloma Multiplo, 6 June 2017, Tavola Rotonda BMS, Policlinico Federico II, Napoli
18) Il trattamento medico dell’anemia nella pratica clinica con Epoietina La gestione delle alterazioni della crasi ematica e delle tossicità da chemioterapia: confronto tra esperti – IV Edizione – 15 June 2017, Hotel Montespina, Napoli
19) Il Mieloma Multiplo: innovazioni nei trattamenti di prima linea e linee successive La gestione delle alterazioni della crasi ematica e delle tossicità da chemioterapia: confronto tra esperti – IV Edizione – 15 June 2017, Hotel Montespina, Napoli
10
20) Front-line vascular access devices in acute leukemias – Peripherally inserted central catheter (PICCs) versus traditional central venous catheter (CVCs): a phase IV randomized trial (NCT02405728) Oral comunication - European Hematology Association (EHA) 2017, 24 June 2017, Madrid, Spain
21) L’immunoterapia: una tripletta differente - Il Mieloma Multiplo: dalla prima linea alla recidiva – 30 September 2017, Naples, Italy
22) Front-line vascular access devices in acute leukemias – Peripherally inserted central catheter (PICCs) versus traditional central venous catheter (CVCs): a phase IV randomized trial – an update (NCT02405728) Oral comunication – Italian Society of Hematology 2017, 16 October 2017, Roma, Italy
23) Leucemia Mieloide Cronica – l’ingresso in clinica dei generici: opportunità e preoccupazioni. La Medicina Narrativa nell’era della Precision Medicine – Le Medical Humanities in Ematologia, Oncologia e Terapia del dolore – 10 November 2017, Sala Convegni Croce Rossa Italiana, Naples, Italy
24) L’approccio terapeutico nel Mieloma Multiplo – Nuovi scenari in Ematologia, 1 December 2017, Palazzo Esedra, Naples, Italy
25) Lenalidomide in Mantle Cell Lymphoma Patients and MRD status in MRD: clinical impact in hematological maligancies – 7 September 2018 - IRST IRCCS Meldola (FC)
26) Training Ixazomib in Multiple Myeloma – Takeda Italia – Roma + Bologna, 12 September, 10 October 2018
27) Moderatore Sessione “Registry, big data and interpretation” in “Nuove frontiere del NGS nella diagnostica ematologica” - 25 October 2018 – IRST IRCCS Meldola (FC)
28) Combined oral administration of analgesia and anxiolysis for pain associated with bone marrow aspiration and biopsy Oral comunication – Italian Society of Experimental Hematology 2018, 18 October 2018, Rimini, Italy
29) Relatore “IMIDs e la modulazione del microambiente nel Mieloma Multiplo: le nuove indicazioni della Lenalidomide e nuove opportunità della Polmalidomide” in “L’ematologia, l’Oncologia e la medicina del dolore tra umanizzazione delle cure e precision medicine” – 26 October 2018 - Sala Convegni Croce Rossa Italiana – Napoli
30) Scientific Responsible of Master in Pediatric OncoHematology – A.O.R.N. Santobono-Pausilipon – Napoli – 2018/2019
Papers:
1) Cerchione C, Fabbricini R, Pane F, Luciano L.
Vitiligo-like lesions in an adult patient treated with Imatinib Mesylate
11
Leuk Res.2009 Aug; 33(8): e104-5.
2) Pane F, Quintarelli F, Esposito N, Izzo B, De Angelis B, Peluso A, Muccioli Casadei G, Cosenza M, Cerchione C, Camera A, Luciano L. Acute and Chronic Ph+ Leukemias: differential leukemogenesis pathways translate into different clinical needs Hematologica, Vol.94, October 2009.
3) Cerchione C, Catalano L, Cerciello G, Avilia S, Picardi M, Risitano AM, Pisano I,
Alfinito F, Pane F. Role of Lenalidomide in the management of myelodysplastic syndromes with del(5q) associated with pure red cell aplasia (PRCA) Ann Hematol. 2015 Mar; 94(3): 531-4.
4) Cerchione C, Catalano L, Pareto AE, Picardi M, Pane F.
Pegfilgrastim in primary prophylaxis of febrile neutropenia during chemotherapy of relapsed and refractory multiple myeloma: a real-life experience Support Care Cancer. 2015 Feb; 23(2): 301-2.
5) Fonti R, Pace L, Cerchione C, Catalano L, Salvatore B, De Luca S, Pane F, Salvatore M, Del Vecchio S.
18-FDG PET/CT, 99mTc-MIBI, and MRI in the prediction of outcome of patients with Multiple Myeloma: a comparative study Clin Nucl Med 2015 Apr; 40(4): 303-8
6) Cerchione C, Lucignano M, Pane F, Catalano L.
Salvage therapy with pegylated liposomial doxorubicin-based regimen in relapsed/refractory multiple myeloma: comments to the article by Romano et al. Eur J Haematol. 2016 May; 96(5): 544.
7) Cerchione C, Catalano L, Peluso I, Nappi D, Di Perna M, Salvatore D, Migliaccio I, Picardi M, Pane F.
Managing neutropenia by pegfilgrastim in patients affected by relapsed/refractory multiple myeloma treated with bendamustine-bortezomib-dexamethasone Support Care Cancer. 2016 Dec; 24(12): 4835-4837.
8) Cerchione C, De Renzo A, Di Perna M, Della Pepa R, Pugliese N, Catalano L, Pane F, Picardi M.
Pegfilgrastim in primary prophylaxis of febrile neutropenia following front-line bendamustine plus rituximab treatment in patients with indolent non Hodgkin lymphoma: a single center, real-life experience Support Care Cancer. 2017 Mar; 25(3): 839-845.
9) Cerchione C, Nappi D, Di Perna M, Zacheo I, Pareto AE, Picardi M, Catalano L, Pane F.
Retreatment with Bendamustine-Bortezomib-Dexamethasone in a patient with relapsed/refractory multiple myeloma Case Rep Hematol. 2016; 2016: 6745286.
10) Cerchione C, Cerciello G, Avilia S, Della Pepa R, Pugliese N, Picardi M, Pane F, Catalano L.
Management of iron overload in myelodysplastic syndromes: combined deferasirox and deferoxamine in a patient with liver disease Blood Transfus. 2016 Oct 24; 1-4.
11) Della Pepa R, Pagano L, Cerchione C, Pugliese N, Pane F, Picardi M.
Reply to the letter to the editor "chronic disseminated candidiasis" by Kenneth Rolston Support Care Cancer. 2017 Apr; 25(4): 1045-1046.
12) Pugliese N, Di Perna M, Cozzolino I, Ciancia G, Pettinato G, Zeppa P, Varone V, Masone S, Cerchione C, Della Pepa R,
Simeone L, Salvatore C, Pane F, Picardi M. Randomized comparison of power Doppler ultrasonography-guided core-needle biopsy with open surgical biopsy for the characterization of lymphadenopathies in patients with suspected lymphoma Ann Hematol. 2017 Apr; 96(4): 627-637.
13) Cerchione C, Peluso I, Nappi D, Pareto AE, Picardi M, Martinelli V, Pane F.
Ruxolitinib rechallenge in combination with hydroxyurea is effective in reverting cachexia and reducing blood transfusion demand and splenomegaly symptoms in a patient with primary myelofibrosis Ann Hematol. 2017 Apr; 96(4): 697-699.
12
14) Cerchione C, Nappi D, Di Perna M, Zacheo I, Migliaccio I, Salvatore D, Picardi M, Pane F, Catalano L.
A case of efficacy of bendamustine in heavily pretreated multiple myeloma, refractory to pomalidomide Clinical Case reports, Vol 5, Issue 4, April 2017 Pages 505-507.
15) Cerchione C, Maraolo AE, Marano L, Pugliese N, Nappi D, Tosone G, Cimmino I, Cozzolino I, Martinelli V, Pane F,
Picardi M. Secondary syphilis mimicking malignancy: A case report and review of literature J Infect Chemother. 2017 Aug; 23(8): 576-578.
16) Pugliese N, Salvatore P, Iula VD, Catania MR, Chiurazzi F, Della Pepa R, Cerchione C, Raimondo M, Giordano C, Simeone
L, Caruso S, Pane F, Picardi M. Ultrasonography-driven tigecycline-based antibiotic therapy significantly increases survival among patients with neutropenic enterocolitis following cytarabine-containing chemotherapy for the remission induction of acute myeloid leukemia Cancer Med. 2017. Jul; 6(7): 1500-1511.
17) Fiore M, Maraolo AE, Chiodini P, Cerchione C, Gentile I, Borgia G, Pace MC.
Is anticoagulation with novel oral anticoagulants an effective treatment for tubercolosis patients not achieving a therapeutic range with vitamin k antagonists? A Systematic Review. Cardiovasc Hematol Disord Drug Targets. 2017; 17(2): 105-110.
18) Della Pepa R, Picardi M, Giordano C, Zacheo I, Pugliese N, Cerchione C, Raimondo M, Di Perna M, Troncone G, Ciancia G, Intrieri M, Pane F. Rituximab in a risk-adapted treatment strategy gives excellent therapeutic results in nodular lyphocyte-predominant Hodgkin lymphoma Br J Haematol. 2017 Jul 24.
19) Mondello P, Steiner N, WIllenbacher W, Cerchione C, Nappi D, Mauro E, Ferrero S, Cuzzocrea S, Mian M. Bendamustine plus Rituximab Versus R-CHOP as First-Line Treatment for Patients with Follicular Lymphoma Grade 3A: Evidence from a Multicenter, Retrospective Study. Oncologist. 2018 Jan 9.
20) Romano A, Laura Parrinello N, Cerchione C, Letizia Consoli M, Parisi M, Calafiore V, Martino E, Conticello C, Di Raimondo F, Alberto Palumbo G. The NLR and LMR ratio in newly diagnosed MM patients treated upfront with novel agents. Blood Cancer J. 2017 Dec 15; 7(12): 649.
21) Romano A, Cerchione C, Consoli M, Parisi M, Calafiore V, Martino E, Conticello C, Di Raimondo F, Palumbo G The neutrophil-lymphocyte ratio (NLR) and the lymphocyte-monocyte ratio (LMR) predict progression free survival in patients with newly diagnosed multiple myeloma treated upfront with novel agents Blood Cancer J. 2017 Dec 15; 7(12): 649.
22) Cerchione C, Nappi D, Pareto AE, Romano A, Picardi M, Pane F, Catalano L Lenalidomide at the dose of twenty-five mg every other day in patients affected by multiple myeloma and renal failure: a real-life experience Anticancer Drugs. 2018 Feb 7.
23) Della Pepa R, Cerchione C, Pugliese N, Colicchio R, Salvatore P, Sirignano C, Soscia E, Pagano L, Sanguinetti M, Pane F, Picardi M. Diagnostic-driven antifungal approach in neutropenic patients at high risk for chronic disseminated candidiasis: preliminary osbservations on role of 1,3-beta-D-glucan antigenemia and multiphasic contrast-enhanced computed tomography Support Care Cancer. 2018 Mar 9.
24) Cerchione C, Nappi D, Pareto AE, Di Perna M, Zacheo I, Picardi M, Pane F, Catalano L Safety and comfort of domestic bortezomib injection in real life experience Support Care Cancer 2018 Mar 24.
Abstracts/Poster presentations in national/international events:
13
1) Luciano L, Cerchione C, Becchimanzi C, Pane F, Rotoli B. “Imatinib Mesylate and Cardiac function” Haematologica Abstract Book, SIE, Vol. 92 supplement no.3, October 2007
2) V. Schiano Lomoriello, R. Esposito, R.Viceconti, C.Cerchione, L.Luciano, M.Galderisi
“L'Imatinib aumenta la massa ventricolare ed il diametro atriale sinistro nei pazienti affetti da leucemia mieloide cronica” Giornale Italiano di Cardiologia volume 9, Suppl.2 al n.5 May 2008
3) Olim P, Sousa P, Carda J, Sousa M.I., Tavares P, Cerchione C
“Linfoma osseo primario – a experiencia de uma instituicao” Abstract Congresso Nazionale Società Portoghese di Ematologia September 2008
4) Luciano L, Cerchione C, Schiano Lomoriello V, Esposito R, Fabbricini R, Galderisi M, Pane F, Rotoli B
“Effect of Imatinib Mesylate on cardiac function” Haematologica Abstract Book, SIES, Vol. 93 supplement no.2, September 2008
5) Caliendo I, Luciano L, Danise P, Rivellini F, De Vita B, Guerriero A, Cerchione C, Tafuri A, Clemente L, Ingenito M, D'Arco
A “Progression of a myelodysplastic syndrome, with nonrandom aneuploidy of chromosome 21, to acute myeloid leukemia with t(9;15) (q22;q22) as the sole cytogenetic abnormality” Haematologica Abstract Book, SIES, Vol. 93 supplement no.2, September 2008
6) Luciano L, Cerchione C, Ciancia R, Pane F
“Renal failure associated to tyrosine kinase inhibitors” Haematologica Abstract Book, EHA, Vol. 95 supplement no.2, June 2010
7) Luciano L, Cerchione C, Ciancia R, Pane F
“Successful pregnancies in Chronic Myeloid Leukaemia male patient on Imatinib therapy” Haematologica Abstract Book, EHA, Vol. 95 supplement no.2, June 2010
8) Cerchione C, Luciano L, Ciancia R, Pane F
“Renal failure associated to tyrosine kinase inhibitors” Abstract Book Riunione Annuale dei Centri di Ematologia Meridionale ed Insulare (SIE SUD), con Comunicazione Orale
9) Cerchione C, Luciano L, Ciancia R, Pane F
“Successful pregnancies in Chronic Myeloid Leukaemia male patient on Imatinib therapy” Abstract Book Riunione Annuale dei Centri di Ematologia Meridionale ed Insulare (SIE SUD), con Comunicazione Orale
10) Cerchione C, Luciano L, Ciancia R, Pane F
“LA PATERNITA’ NEI PAZIENTI CON LEUCEMIA MIELOIDE CRONICA IN TERAPIA CON GLI INIBITORI DELLE TIROSINCHINASI” Abstract Book Giornate Scientifiche “Bruno Rotoli” Federico II
11) Cerchione C, Luciano L, Ciancia R, Pane F
“NEFROTOSSICITA' NEI PAZIENTI CON LEUCEMIA MIELOIDE CRONICA IN TERAPIA CON GLI INIBITORI DELLE TIROSINCHINASI” Abstract Book Giornate Scientifiche “Bruno Rotoli” Federico II
12) Della Pepa R., Cacciapuoti V., Cerciello G., Avilia S., Cerchione C., Luciano L., Alfinito F., Pane F.
“La tecnica FISH (Fluorescent In Situ Hybridization) è un ottimo strumento per migliorare la diagnosi delle
Sindromi Mielodisplastiche Primarie (MDS)”
Abstract Book Giornate Scientifiche “Bruno Rotoli” Federico II
13) Cerchione C, Cerciello G, Della Pepa R, Ciancia R, Matarazzo M, Alfinito F, Pane F “Combination of deferasirox and deferoxamine for management of iron overload in myelodysplastic syndromes in hepatopathic patient: A case report” Leukemia Research, Volume 35, Supplement 1, S1-S166 (May 2011)
14) Cerciello G, Cerchione C, Cosenza M, Luciano L, Alfinito F, Pane F, Risitano AM
“Myelodysplastic syndromes and pure red cell aplasia with del (5q)”
14
Leukemia Research, Volume 35, Supplement 1, S1-S166 (May 2011)
15) Cerchione C, Cerciello G, Della Pepa R, Ciancia R, Matarazzo M, Alfinito F, Pane F “Safety and efficacy of combination therapy with Deferasirox and Deferoxamine for management of iron overload in multitransfused hepatopatic patient with myelodysplastic syndrome: a case report” Haematologica Abstract Book, EHA London, Vol. 96 supplement no.2, June 2011
16) Della Pepa R, Cerchione C, Cerciello G, Izzo B, Muccioli Casadei G, Alfinito F, Pane F
“Myelodysplastic syndromes with del(5q) and JAK2 V617F mutation: a case of hematologic response to Lenalidomide therapy” Haematologica Abstract Book, EHA London, Vol. 96 supplement no.2, June 2011
17) Pugliese N, Gravetti A, Quintarelli C, Madonna E, Izzo B, Muccioli Casadei G, Cerchione C, Martinelli V, Pane F
“Hydroxyurea plus Anagrelide combined therapy is more suitable than sequence schedule of the two drugs” Haematologica Abstract Book, EHA London, Vol. 96 supplement no.2, June 2011
18) Ciancia R, Cerchione C, Seneca E, Beneduce G, Pisano I, Cacciapuoti V, Luciano L, Pane F
“Myelodysplastic/myeloproliferative neoplasm: a future therapeutic perspective” Haematologica Abstract Book, SIE Napoli, Vol. 96 supplement no.3, October 2011
19) Cerchione C, Cerciello G, Della Pepa R, Avilia S, Ciancia R, Matarazzo M, Alfinito F, Pane F
“Management of iron overload in myelodysplastic syndromes (MDS): combination of deferasirox and deferoxamine in a hepatopatic patient” Haematologica Abstract Book, SIE Napoli, Vol. 96 supplement no.3, October 2011
20) Cerciello G, Cerchione C, Della Pepa R, Avilia S, Cosenza M, Luciano L, Alfinito F, Pane F, Risitano AM
“Pure red cell aplasia (PRCA) and myelodysplastic syndromes (MDS) with del (5q)” Haematologica Abstract Book, SIE Napoli, Vol. 96 supplement no.3, October 2011
21) Della Pepa R, Cerchione C, Cerciello G, Avilia S, Izzo B, Muccioli Casadei G, Alfinito F, Pane F
“Hematologic response to Lenalidomide in JAK2 V617F-positive essential thrombocytemia (TE) associated to del (5q) myelodysplastic syndrome: a case report” Haematologica Abstract Book, SIE Napoli, Vol. 96 supplement no.3, October 2011
22) Luciano L, Seneca E, Cerchione C, Ciancia R, Pisano I, Cosenza M, Peluso AL, Pane F
“A particular mutational status in a chronic myeloid leukemia patient treated with different tyrosin-kinase inhibitors” Haematologica Abstract Book, SIE Napoli, Vol. 96 supplement no.3, October 2011
23) Pugliese N, Marano L, Gherghi M, Quintarelli C, De Angelis B, Cerchione C, Errichiello S, Muccioli Casadei G, Beneduce
G, Martinelli V, Pane F “Anagrelide in monotherapy or combined with hydroxyurea yields a high rate of complete response in Essential Thrombocythemia” Haematologica Abstract Book, EHA Amsterdam, Vol.97 supplement no.1, June 2012
24) Pugliese N, Marano L, Picardi M, Gherghi M, Ciancia G, Cerchione C, Quintarelli C, Martinelli V, Pane F
“Spleen is the hidden hitch of Essential Thrombocythemia” Haematologica Abstract Book, EHA Amsterdam, Vol.97 supplement no.1, June 2012
25) Cerchione C, Cerciello G, Della Pepa R, Matarazzo M, Alfinito F, Pane F
“Deferasirox and Deferoxamine combination therapy: a case of management of iron overload in Myelodysplastic Syndrome in an hepatopathic patient” Haematologica Abstract Book, EHA Amsterdam, Vol.97 supplement no.1, June 2012
26) Cerchione C, Battipaglia G, Migliaccio I, Salvatore S, Camera A, Cerciello G, Della Pepa R, Chiurazzi F, Pane F “Secondary hemophagocytic lymphohistiocytosis five years after acute myeloid leukemia: a case report” Haematologica Abstract Book, Sies Roma, Vol.97 supplement no.2, October 2012
27) Claudio Cerchione, Fabrizio Pane, Marco Picardi “Monitoraggio dei livelli plasmatici degli antimicotici azolici nei pazienti neutropenici e correlazioni con efficacia terapeutica ed effetti tossici” Presentazione al Progetto Under40 in Hematology, Napoli 2012
15
28) C. Cerchione, V. Russo, F. Tucci, G. Loffredo, N. Marra, R. Parasole, F. Petruzziello, N. Crescenzio, G. Menna, V. Poggi
“La sindrome autoimmune linfoproliferativa (ALPS): Esperienza del nostro centro AIEOP” Librone abstract XXXVIII Congresso nazionale AIEOP, Roma, Giugno 2013
29) C. Cerchione, V. Russo, F. Tucci, G. Loffredo, N. Marra, R. Parasole, F. Petruzziello, V. Poggi
“Un caso di PTT in età pediatrica” Librone abstract XXXVIII Congresso nazionale AIEOP, Roma, Giugno 2013
30) C. Cerchione, G. Cerciello, R. Della Pepa, N. Pugliese, L. Marano, O. Vitagliano, M. Matarazzo, F. Pane, F. Alfinito
Hematology, University of Naples “Federico II”, Naples, Italy “Combination of Deferasirox and Deferoxamine in management of iron overload in Myelodysplastic syndromes (MDS): an update in a hepatopatic patient” MDS Foundation 2013, Berlin, Abstract Book Leukemia Research, supplement May 2013
31) C. Cerchione, G. Cerciello, R. Della Pepa, N. Pugliese, L. Marano, O. Vitagliano, L. Luciano, F. Alfinito, F. Pane, A.M.
Risitano Hematology, University of Naples “Federico II”, Naples, Italy “Role of Lenalidomide in management of Pure Red Cell Aplasia (PRCA) and Myelodysplastic Syndromes (MDS) with del (5q)” MDS Foundation 2013, Berlin, Abstract Book Leukemia Research, supplement May 2013
32) P. Danise, O. Vitagliano, C. Cerchione, I. Soriente, A.M. D’Arco, F. Pane, F. Alfinito
Hematology, University of Naples “Federico II”, Naples, Italy “Erythropoietic aspects in MDS patients responders to ESAs treatment” MDS Foundation 2013, Berlin, Abstract Book Leukemia Research, supplement May 2013
33) Claudio Cerchione, Emanuela Madonna, Luana Marano, Novella Pugliese, Simona Avilia, Giuseppe Cerciello, Fabrizio
Pane, Lucio Catalano BENDAMUSTINE: A NEW OPTION FOR RELAPSED/REFRACTORY MULTIPLE MYELOMA Haematologica Abstract Book, EHA Stockholm, Vol.98 supplement no.1, June 2013
34) Claudio Cerchione, Emanuela Madonna, Rossella Fabbricini, Luana Marano, Novella Pugliese, Fabrizio Pane, Lucio
Catalano A NEW OPPORTUNITY IN RELAPLSED AND REFRACTORY MULTIPLE MYELOMA: PEGYLATED LIPOSOMAL DOXORUBICIN, CYCLOPHOSPHAMIDE AND DEXAMETHASONE (CED) Haematologica Abstract Book, EHA Stockholm, Vol.98 supplement no.1, June 2013
35) Claudio Cerchione, Emanuela Madonna, Rossella Fabbricini, Luana Marano, Novella Pugliese, Simona Avilia, Giuseppe
Cerciello, Fabrizio Pane, Lucio Catalano TWENTY-FIVE MG LENALIDOMIDE EVERY OTHER DAY IN PATIENTS AFFECTED BY MULTIPLE MYELOMA AND RENAL FAILURE Haematologica Abstract Book, EHA Stockholm, Vol.98 supplement no.1, June 2013
36) Claudio Cerchione, Novella Pugliese, Luana Marano, Giuseppe Cerciello, Simona Avilia, Fabrizio Pane, Lucio Catalano
PEGFILGRASTIM AS PROPHYLAXIS OF FEBRILE NEUTROPENIA DURING CHEMOTHERAPY OF RELAPSED AND REFRACTORY MULTIPLE MYELOMA Haematologica Abstract Book, EHA Stockholm, Vol.98 supplement no.1, June 2013
37) Claudio Cerchione, Emanuela Madonna, Rossella Fabbricini, Luana Marano, Novella Pugliese, Simona Avilia, Giuseppe
Cerciello, Fabrizio Pane, Lucio Catalano DOMESTIC SUBCUTANEOUS SELF-INJECTION OF BORTEZOMIB IN MULTIPLE MYELOMA Haematologica Abstract Book, EHA Stockholm, Vol.98 supplement no.1, June 2013
38) Paolo Danise, Claudio Cerchione, Orsola Vitagliano, Ilaria Soriente, Alfonso Maria D'Arco, Fabrizio Pane, Fiorella Alfinito
ERYTHROPOIETIC ASPECTS IN MDS PATIENTS RESPONDERS TO ESAS TREATMENT Haematologica Abstract Book, EHA Stockholm, Vol.98 supplement no.1, June 2013
39) Fiorella Alfinito, Orsola Vitagliano, Claudio Cerchione, Giovanna Giagnuolo, Ilaria Soriente, Alfonso Maria D'Arco, Paolo
Danise, Fabrizio Pane ANALYSIS OF RESPONSE TO ERYTHROPOYESIS STIMULATING AGENTS (ESAS) IN 114 MYELODYSPLASTIC SYNDROME (MDS) PATIENTS FROM REGISTRO CAMPANO DELLE MIELODISPLASIE
16
Haematologica Abstract Book, EHA Stockholm, Vol.98 supplement no.1, June 2013
40) Novella Pugliese, Claudio Cerchione, Francesco Grimaldi, Marta Raimondo, Maria Di Perna, Simona Pagliuca, Fabrizio Pane, Marco Picardi BENDAMUSTINE-BASED THERAPY IS EFFECTIVE AND HAS A FAVOURABLE TOXICITY PROFILE IN THE TREATMENT OF REFRACTORY AND RELAPSED HODGKIN LYMPHOMA. Haematologica Abstract Book, EHA Stockholm, Vol.98 supplement no.1, June 2013
41) Novella Pugliese, Concetta Quintarelli, Biagio De Angelis, Luana Marano, Santa Errichiello, Claudio Cerchione, Marco
Picardi, Vincenzo Martinelli, Fabrizio Pane THE INTERFERON SCORE TOWARDS PREDICTION OF RESPONSIVNESS TO INTERFERON ALPHA IN ESSENTIAL THROMBOCYTHEMIA Haematologica Abstract Book, EHA Stockholm, Vol.98 supplement no.1, June 2013
42) Novella Pugliese, Concetta Quintarelli, Biagio De Angelis, Santa Errichiello, Luana Marano, Maddalena Raia, Claudio
Cerchione, Luigi Del Vecchio, Marco Picardi, Vincenzo Martinelli, Fabrizio Pane ALL-TRANS RETINOIC ACID POTENTIATES THE INHIBITORY EFFECTS OF INTERFERON ALPHA (IFN) ON CHRONIC MYELOPROLIFERATIVE NEOPLASMS (MPN) PROGENITORS IN VITRO. Haematologica Abstract Book, EHA Stockholm, Vol.98 supplement no.1, June 2013
43) Giovanna Giagnuolo, Claudio Cerchione, Piera Angelillo, Orsola Vitagliano, Novella Pugliese, Luana Marano, Giorgia
Battipaglia, Simona Avilia, Fiorella Alfinito, Giuseppe Cerciello, Fabrizio Pane BENEFITS OF THE USE OF AZACITIDINE IN PATIENTS WITH AML REFRACTORY OR RELAPSED AFTER INTENSIVE CHEMOTHERAPY Haematologica Abstract Book, EHA Stockholm, Vol.98 supplement no.1, June 2013
44) Claudio Cerchione, Giuseppe Cerciello, Roberta Della Pepa, Novella Pugliese, Luana Marano, Orsola Vitagliano, Luigia
Luciano, Fiorella Alfinito, Fabrizio Pane, Antonio Maria Risitano ROLE OF LENALIDOMIDE IN MANAGEMENT OF MYELODYSPLASTIC SYNDROMES (MDS) WITH DEL(5Q) ASSOCIATED WITH PURE RED CELL APLASIA (PRCA) Haematologica Abstract Book, EHA Stockholm, Vol.98 supplement no.1, June 2013
45) Claudio Cerchione, Giuseppe Cerciello, Roberta Della Pepa, Novella Pugliese, Luana Marano, Orsola Vitagliano,
Margherita Matarazzo, Fabrizio Pane, Fiorella Alfinito COMBINATION OF DEFERASIROX AND DEFEROXAMINE IN MANAGEMENT OF IRON OVERLOAD IN MYELODYSPLASTIC SYNDROMES (MDS): AN UPDATE IN A HEPATOPATIC PATIENT Haematologica Abstract Book, EHA Stockholm, Vol.98 supplement no.1, June 2013
46) Giusi Barra, Claudio Cerchione, Emanuela Madonna, G.Pasquale, A.Sementa, Fabrizio Pane, Lucio Catalano, Raffaele
De Palma SPHINGOSINE KINASE 2 IS OVEREXPRESSED IN PATIENTS AFFECTED BY MULTIPLE MYELOMA Haematologica Abstract Book, EHA Stockholm, Vol.98 supplement no.1, June 2013
47) Claudio Cerchione, Giovanna Giagnuolo, Piera Angelillo, Simona Avilia, Orsola Vitagliano, Novella Pugliese, Luana
Marano, Anna Pareto, Fiorella Alfinito, Fabrizio Pane, Giuseppe Cerciello BENEFITS OF THE USE OF AZACITIDINE IN PATIENTS WITH AML REFRACTORY OR RELAPSED AFTER INTENSIVE CHEMOTHERAPY XXVI Symposium IACRLRD (International Association for Comparative Research on Leukemia and Related Diseases), Torino 2013, Abstract Book
48) Novella Pugliese, Concetta Quintarelli, Biagio De Angelis, Santa Errichiello, Luana Marano, Nicola Esposito, Claudio
Cerchione, Marco Picardi, Vincenzo Martinelli, Fabrizio Pane INTERFERON SIGNATURE PREDICTS RESPONSIVENESS IN ESSENTIAL THROMBOCYTHEMIA XXVI Symposium IACRLRD (International Association for Comparative Research on Leukemia and Related Diseases), Torino 2013, Abstract Book
49) Novella Pugliese, Concetta Quintarelli, Biagio De Angelis, Santa Errichiello, Luana Marano, Maddalena Raia, Claudio
Cerchione, Luigi Del Vecchio, Marco Picardi, Vincenzo Martinelli, Fabrizio Pane IN VITRO SINERGISTIC INHIBITORY EFFECTS USING COMBINATION OF INTERFERON ALPHA AND ALL-TRANS RETINOIC ACID IN CHRONIC MYELOPROLIFERATIVE NEOPLASMS (MPN) XXVI Symposium IACRLRD (International Association for Comparative Research on Leukemia and Related Diseases), Torino 2013, Abstract Book
17
50) Claudio Cerchione, Emanuela Madonna, Luana Marano, Novella Pugliese, Elisa Seneca, Simona Avilia, Giuseppe
Cerciello, Fabrizio Pane, Lucio Catalano MANAGEMENT OF MULTIPLE MYELOMA WITH BENDAMUSTINE: A FURTHER OPTION FOR RELAPSED AND REFRACTORY PATIENTS XXVI Symposium IACRLRD (International Association for Comparative Research on Leukemia and Related Diseases), Torino 2013, Abstract Book
51) Claudio Cerchione, Novella Pugliese, Luana Marano, Giuseppe Cerciello, Simona Avilia, Elisa Seneca, Fabrizio Pane,
Lucio Catalano PEGFILGRASTIM IN THE MANAGEMENT OF POSTCHEMOTHERAPY FEBRILE NEUTROPENIA IN RELAPSED AND REFRACTORY MULTIPLE MYELOMA XXVI Symposium IACRLRD (International Association for Comparative Research on Leukemia and Related Diseases), Torino 2013, Abstract Book
52) Claudio Cerchione, Paolo Danise, Orsola Vitagliano, Giuseppe Cerciello, Anna Pareto, Ilaria Soriente, Alfonso Maria
D’Arco, Fabrizio Pane, Fiorella Alfinito EVALUATION OF ERYTHROPOIETIC ASPECTS IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES RESPONDERS TO ERYTRHOPOIESIS STIMULATING AGENTS (ESAs) XXVI Symposium IACRLRD (International Association for Comparative Research on Leukemia and Related Diseases), Torino 2013, Abstract Book
53) Claudio Cerchione, Emanuela Madonna, Luana Marano, Novella Pugliese, Simona Avilia, Giuseppe Cerciello, Fabrizio
Pane, Lucio Catalano MANAGEMENT OF MULTIPLE MYELOMA WITH BENDAMUSTINE: A FURTHER OPTION FOR RELAPSED AND REFRACTORY PATIENTS Haematologica Abstract Book, SIE Verona, Vol.98 supplement no.3, October 2013
54) Claudio Cerchione, Novella Pugliese, Luana Marano, Giuseppe Cerciello, Simona Avilia, Elisa Seneca, Fabrizio Pane,
Lucio Catalano PEGFILGRASTIM IN THE MANAGEMENT OF POST-CHEMOTHERAPY FEBRILE NEUTROPENIA IN RELAPSED AND REFRACTORY MULTIPLE MYELOMA Haematologica Abstract Book, SIE Verona, Vol.98 supplement no.3, October 2013
55) Paolo Danise, Claudio Cerchione, Orsola Vitagliano, Giuseppe Cerciello, Ilaria Soriente, Alfonso Maria D'Arco, Fabrizio
Pane, Fiorella Alfinito EVALUATION OF ERYTHROPOIETIC ASPECTS IN PATIENTS WITH MYELODISPLASTIC SYNDROMES RESPONDERS TO ERYTHROPOIESIS STIMULATING AGENTS Haematologica Abstract Book, SIE Verona, Vol.98 supplement no.3, October 2013
56) Fiorella Alfinito, Claudio Cerchione, Orsola Vitagliano, Giovanna Giagnuolo, Giuseppe Cerciello, Ilaria Soriente, Alfonso
Maria D'Arco, Paolo Danise, Fabrizio Pane ERYTHROPOYESIS STIMULATING AGENTS (ESAS) IN THE MANAGEMENT OF MYELODYSPLASTIC SYNDROMES Haematologica Abstract Book, SIE Verona, Vol.98 supplement no.3, October 2013
57) Novella Pugliese, Claudio Cerchione, Francesco Grimaldi, Marta Raimondo, Maria Di Perna, Simona Pagliuca, Fabrizio
Pane, Marco Picardi EFFICACY AND SAFETY OF BENDAMUSTINE-BASED REGIMEN IN THE TREATMENT OF REFRACTORY AND RELAPSED HODGKIN LYMPHOMA. Haematologica Abstract Book, SIE Verona, Vol.98 supplement no.3, October 2013
58) Novella Pugliese, Concetta Quintarelli, Biagio De Angelis, Luana Marano, Santa Errichiello, Nicola Esposito, Claudio
Cerchione, Marco Picardi, Vincenzo Martinelli, Fabrizio Pane GENE EXPRESSION DRIVES INTERFERON TAILORED THERAPY IN ESSENTIAL THROMBOCYTHEMIA Haematologica Abstract Book, SIE Verona, Vol.98 supplement no.3, October 2013
59) Novella Pugliese, Concetta Quintarelli, Biagio De Angelis, Santa Errichiello, Luana Marano, Maddalena Raia, Claudio
Cerchione, Luigi Del Vecchio, Marco Picardi, Vincenzo Martinelli, Fabrizio Pane SINERGISTIC INTERACTION BETWEEN ALL-TRANS RETINOIC ACID AND INTERFERON ALPHA IN VITRO MODEL OF CHRONIC MYELOPROLIFERATIVE NEOPLASMS (MPN) Haematologica Abstract Book, SIE Verona, Vol.98 supplement no.3, October 2013
18
60) Claudio Cerchione, Giuseppe Cerciello, Roberta Della Pepa, Novella Pugliese, Luana Marano, Orsola Vitagliano, Luigia Luciano, Fiorella Alfinito, Fabrizio Pane, Antonio Maria Risitano MANAGEMENT OF MYELODYSPLASTIC SYNDROMES (MDS) WITH DEL(5Q) ASSOCIATED WITH PURE RED CELL APLASIA (PRCA): ROLE OF LENALIDOMIDE Haematologica Abstract Book, SIE Verona, Vol.98 supplement no.3, October 2013
61) Claudio Cerchione, Vincenzo Russo, Francesca Tucci, Giuseppe Loffredo, Giuseppe Menna, Rosanna Parasole, Fara
Petruzziello, Nicoletta Marra, Francesco Menna, Nicoletta Crescenzio, Vincenzo Poggi AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME (ALPS): EXPERIENCE OF OUR AIEOP DEPARTMENT Haematologica Abstract Book, SIE Verona, Vol.98 supplement no.3, October 2013
62) Giovanna Giagnuolo, Claudio Cerchione, Piera Angelillo, Simona Avilia, Orsola Vitagliano, Novella Pugliese, Luana
Marano, Fiorella Alfinito, Fabrizio Pane, Giuseppe Cerciello BENEFITS OF THE USE OF AZACITIDINE IN PATIENTS WITH AML REFRACTORY OR RELAPSED AFTER INTENSIVE CHEMOTHERAPY Haematologica Abstract Book, SIE Verona, Vol.98 supplement no.3, October 2013
63) Fonti R, Pace L, Cerchione C, Catalano L, Seneca E, Madonna E, De Luca S, Pane F, Salvatore M, Del Vecchio S.
ROLE OF 18-FDG-PET/CT, 99MTC-MIBI AND MRI IN THE PREDICTION OF OUTCOME OF MULTIPLE MYELOMA Haematologica Abstract Book, SIE Verona, Vol.98 supplement no.3, October 2013
64) Barra G, Cerchione C, Madonna E, Pasquale G, Sementa A, Pane F, Catalano L, De Palma R.
OVEREXPRESSION OF SPHINGOSINE KINASE 2 IN MULTIPLE MYELOMA Haematologica Abstract Book, SIE Verona, Vol.98 supplement no.3, October 2013
65) Luana Marano, Novella Pugliese, Claudio Cerchione, Giuliana Beneduce, Concetta Quintarelli, Biagio De Angelis,
Vincenzo Martinelli, Fabrizio Pane MUCOCUTANEOUS TOXICITY INDUCED BY HYDROXYUREA IN CHRONIC MYELOPROLIFERATIVE NEOPLASMS Haematologica Abstract Book, SIE Verona, Vol.98 supplement no.3, October 2013
66) Novella Pugliese, Luana Marano, Concetta Quintarelli, Biagio De Angelis, Santa Errichiello, Nicola Esposito, Claudio
Cerchione, Marco Picardi, Vincenzo Martinelli, Fabrizio Pane INTERFERON ALPHA IS EFFECTIVE AND HAS A FAVOURABLE TOXICITY PROFILE IN THE TREATMENT OF ESSENTIAL THROMBOCYTHEMIA Haematologica Abstract Book, SIE Verona, Vol.98 supplement no.3, October 2013
67) Novella Pugliese, Concetta Quintarelli, Biagio De Angelis, Luana Marano, Santa Errichiello, Nicola Esposito, Maddalena
Raia, Claudio Cerchione, Luigi Del Vecchio, Marco Picardi, Vincenzo Martinelli, Fabrizio Pane THE INTERFERON SCORE TOWARDS INTERFERON ALPHA TAILORED THERAPY IN ESSENTIAL THROMBOCYTHEMIA ASH Abstract Book, December 2013
68) Claudio Cerchione, Mario Masarone, Marcello Persico, Giuliana Beneduce, Clementina Cimmino, Roberta Della Pepa, Serena Luponio, Ilaria Peluso, Novella Pugliese, Elisa Seneca, Marianna Notarangelo, Ciro Mainolfi, Marco Picardi, Fabrizio Pane, Amalia De Renzo ROLE OF PROPHYLAXIS WITH LAMIVUDINE IN MAINTENANCE TREATMENT WITH RITUXIMAB IN NON HODGKIN LYMPHOMA CD20+ Haematologica Abstract Book, EHA Milano, Vol.99 supplement no.1, June 2014
69) Emanuela Madonna, Luigia Simeone, Marta Raimondo, Claudio Cerchione, Amalia De Renzo, Federico Chiurazzi, Fabrizio Pane SECONDARY MALIGNANCIES IN CHRONIC LYMPHOCYTIC LEUKEMIA: OUR EXPERIENCE Haematologica Abstract Book, EHA Milano, Vol.99 supplement no.1, June 2014
70) Claudio Cerchione, Emanuela Madonna, Anna Emanuele Pareto, Luana Marano, Novella Pugliese, Ilaria Peluso, Elisa Seneca, Giuseppe Cerciello, Simona Avilia, Santina Basile, Fabrizio Pane, Lucio Catalano MANAGEMENT OF RELAPSED AND REFRACTORY MULTIPLE MYELOMA WITH BENDAMUSTINE Haematologica Abstract Book, EHA Milano, Vol.99 supplement no.1, June 2014
71) Amalia De Renzo, Roberta Della Pepa, Serena Luponio, Claudio Cerchione, Giuliana Beneduce, Ilaria Migliaccio, Novella Pugliese, Clementina Cimmino, Elisa Seneca, Anna Emanuele Pareto, Orsola Vitgliano, Luigia Simeone, Fabrizio Pane, Giuseppe Spadaro
19
RITUXIMAB-INDUCED HYPOGAMMAGLOBUINEMIA AND SUPPORTIVE INTRAVENOUS IG (IVIG) TREATMENT IN PATIENTS WITH NON HODGKIN LYMPHOMA Haematologica Abstract Book, EHA Milano, Vol.99 supplement no.1, June 2014
72) Amalia De Renzo, Claudio Cerchione, Fabiana Perna, Mario Masarone, Marcello Persico, Roberta Della Pepa, Clemetina Cimmino, Serena Luponio, Ilaria Peluso, Novella Pugliese, Elisa Seneca, Ciro Mainolfi, Ilario De Sio, Giuseppe Ciancia, Marco Picardi, Fabrizio Pane MANAGEMENT OF PRIMARY HEPATIC NON-HODGKIN’S LYMPHOMA AND CORRELATION WITH HCV INFECTION: EXCELLENT RESULTS WITH CONVENTIONAL CHEMOTHERAPY Haematologica Abstract Book, EHA Milano, Vol.99 supplement no.1, June 2014
73) Novella Pugliese, Elisa Seneca, Lucio Catalano, Marco Picardi, Clementina Cimmino, Claudio Cerchione, Maria Di Perna,
Fabrizio Pane, Amalia De Renzo RISK OF SECOND MULTIPLE MYELOMA AFTER NON-HODGKIN AND HODGKIN LYMPHOMA Haematologica Abstract Book, EHA Milano, Vol.99 supplement no.1, June 2014
74) Claudio Cerchione, Clementina Cimmino, Novella Pugliese, Elisa Seneca, Roberta Della Pepa, Serena Luponio, Ciro Mainolfi, Fabrizio Pane, Amalia De Renzo MANAGEMENT OF RELAPSED/REFRACTORY LYMPHOMA WITH BRENTUXIMAB VEDOTIN: OUR EXPERIENCE IN THE TREATMENT OF YOUNG PATIENTS Haematologica Abstract Book, EHA Milano, Vol.99 supplement no.1, June 2014
75) Claudio Cerchione, Santina Basile, Vincenzo Russo, Elisa Seneca, Fabrizio Pane, Lucio Catalano PEGFILGRASTIM VERSUS FILGRASTIM IN THE MANAGEMENT OF POST-CHEMOTHERAPY NEUTROPENIA IN RELAPSED AND REFRACTORY MULTIPLE MYELOMA Haematologica Abstract Book, EHA Milano, Vol.99 supplement no.1, June 2014
76) Claudio Cerchione, Serena Luponio, Roberta Della Pepa, Ilaria Migliaccio, Giuliana Beneduce, Novella Pugliese, Elisa Seneca, Ernesto Cimino, Antonio Coppola, Anna Maria Cerbone, Antonella Tufano, Marianna Notarangelo, Ilaria Peluso, Giovanni Di Minno, Fabrizio Pane, Amalia De Renzo ACQUIRED HEMOPHILIA IN ELDERLY PATIENTS WITH NON HODGKIN’S LYMPHOMA Haematologica Abstract Book, EHA Milano, Vol.99 supplement no.1, June 2014
77) Claudio Cerchione, Mario Masarone, Marcello Persico, Giuseppe Signoriello, Fabiana Perna, Clementina Cimmino, Novella Pugliese, Elisa Seneca, Ilaria Peluso, Marianna Notarangelo, Fabrizio Pane, Amalia De Renzo PROPHYLAXIS WITH LAMIVUDINE FOR THE PREVENTION OF REACTIVATION IN OCCULT HEPATITIS B (OBI) IN NHL : A COST-EFFECTIVE ANALYSIS Haematologica Abstract Book, EHA Milano, Vol.99 supplement no.1, June 2014
78) Claudio Cerchione, Orsola Vitagliano, Anna Emanuele Pareto, Ilaria Soriente, Paolo Danise, Fiorella Alfinito, Fabrizio Pane Analisi della risposta agli agenti eritrostimolanti in una coorte di pazienti affetti da syndrome mielodisplastica low-risk afferenti al Registro Campano per le MDS Libro dei lavori - Italian Red Cell Club 2014 – San Marcellino e Festo - Napoli
79) Cerchione C, Basile S, Russo V, Seneca E, Pane F, Catalano L MANAGEMENT OF POST-CHEMOTHERAPY NEUTROPENIA IN RELAPSED AND REFRACTORY MULTIPLE MYELOMA: ROLE OF PEGFILGRASTIM Haematologica Abstract Book, SIES Rimini, Vol.99 supplement no.2, October 2014
80) Alfinito F, Cerchione C, Vitagliano O, Pareto AE, Barca R, Cerciello G, Soriente I, D’Arco AM, Pane F, Danise P MANAGEMENT OF MYELODYSPLASTIC SYNDROMES WITH ERYTHROPOIESIS STIMULATING AGENTS: EVALUATION OF ERYTHROPOIETIC ASPECTS AND ANALYSIS OF RESPONSE Haematologica Abstract Book, SIES Rimini, Vol.99 supplement no.2, October 2014
81) Pugliese N, Seneca E, Catalano L, Picardi M, Cimmino C, Luponio S, Cerchione C, Di Perna M, Pane F, De Renzo A INCIDENCE OF MULTIPLE MYELOMA FOLLOWING THERAPY FOR NON-HODGKIN AND HODGKIN LYMPHOMA Haematologica Abstract Book, SIES Rimini, Vol.99 supplement no.2, October 2014
82) Cerchione C, Masarone M, Persico M, Beneduce G, Cimmino C, Luponio S, Pugliese N, Seneca E, Notarangelo M, Mainolfi C, Picardi M, Pane F PROPHYLAXIS WITH LAMIVUDINE IN MAINTENANCE TREATMENT WITH RITUXIMAB IN NON HODGKIN LYMPHOMA CD20+
20
Haematologica Abstract Book, SIES Rimini, Vol.99 supplement no.2, October 2014
83) Cerchione C, De Renzo A, Perna F, Masarone M, Persico M, Della Pepa R, Cimmino C, Luponio S, Pugliese N, Seneca E, Peluso I, Ciancia G, Mainolfi C, De Sio I, Picardi M, Pane F PRIMARY HEPATIC NON-HODGKIN’S LYMPHOMA AND CORRELATION WITH HCV INFECTION: EXCELLENT RESULTS WITH CONVENTIONAL CHEMOTHERAPY Haematologica Abstract Book, SIES Rimini, Vol.99 supplement no.2, October 2014
84) Cerchione C, Madonna E, Pareto AE, Basile S, Peluso I, Vitagliano O, Cimmino C, Simeone L, Seneca E, Pugliese N, Marano L, Pane F, Catalano L ROLE OF BENDAMUSTINE IN RELAPSED AND REFRACTORY MULTIPLE MYELOMA Haematologica Abstract Book, SIES Rimini, Vol.99 supplement no.2, October 2014
85) Cerchione C, Cimmino C, Luponio S, Della Pepa R, Migliaccio I, Beneduce G, Pugliese N, Seneca E, Cimmino E, Coppola A, Cerbone AM, Tufano A, Notarangelo M, Peluso I, Di Minno G, Pane F, De Renzo A MANAGEMENT OF ACQUIRED HEMOPHILIA IN ELDERLY PATIENTS WITH NON HODGKIN’S LYMPHOMA Haematologica Abstract Book, SIES Rimini, Vol.99 supplement no.2, October 2014
86) Cerchione C, Masarone M, Persico M, Perna F, Cimmino C, Peluso I, Notarangelo M, Pane F, De Renzo A COST-EFFECTIVE ANALYSIS OF PROPHYLAXIS WITH LAMIVUDINE FOR THE PREVENTION OF REACTIVATION IN OCCULT HEPATITIS B (OBI) IN PATIENTS WITH NON HODGKIN LYMPHOMA CD20+ UNDERGOING CHEMOTHERAPY WITH AND WITHOUT RITUXIMAB Haematologica Abstract Book, SIES Rimini, Vol.99 supplement no.2, October 2014
87) Cerchione C, Cimmino C, Pugliese N, Seneca E, Mainolfi C, Pane F, De Renzo A BRENTUXIMAB VEDOTIN IN RELAPSED/REFRACTORY LYMPHOMA: OUR EXPERIENCE IN THE TREATMENT OF YOUNG PATIENTS Haematologica Abstract Book, SIES Rimini, Vol.99 supplement no.2, October 2014
88) De Renzo A, Della Pepa R, Luponio S, Cerchione C, Beneduce G, Migliaccio I, Pugliese N, Cimmino C, Seneca E, Pareto AE, Vitagliano O, Simeone L, Pane F, Spadaro G SUPPORTIVE INTRAVENOUS IG (IVIG) TREATMENT IN RITUXIMAB-INDUCED HYPOGAMMAGLOBULINEMIA IN PATIENTS WITH NON HODGKIN LYMPHOMA Haematologica Abstract Book, SIES Rimini, Vol.99 supplement no.2, October 2014
89) Cerchione C, Vitagliano O, Simeone L, Pareto AE, Soriente I, D’Arco AM, Danise P, Alfinito F, Pane F MANAGEMENT OF MYELODYSPLASTIC SYNDROMES WITH ERYTHROPOIESIS STIMULATING AGENTS: EVALUATION OF ERYTHROPOIETIC ASPECTS AND ANALYSIS OF RESPONSE Leuk Res Vol. 39 Suppl 1, S1-S166 (13th International Symposium on Myelodysplastic Syndromes (MDS))
90) Cerchione C, De Renzo A, Masarone M, Cimmino C, Raimondo M, Signoriello G, Notarangelo M, Giagnuolo G, Persico M,
Pane F COST-EFFECTIVE ANALYSIS OF PROPHYLAXIS WITH LAMIVUDINE FOR PREVENTION OF REACRIVATION IN OCCULT HEPATITIS B (OBI) IN PATIENTS WITH NON HODGKIN LYMPHOMA CD20+ UNDERGOING CHEMOTHERAPY Haematologica Abstract Book, EHA Vienna, June 2015
91) Cerchione C, Vitagliano O, Simeone L, Pareto AE, Soriente I, D’Arco AM, Danise P, Alfinito F, Pane F MANAGEMENT OF MYELODYSPLASTIC SYNDROMES WITH ERYTHROPOIESIS STIMULATING AGENTS: EVALUATION OF ERYTHROPOIETIC ASPECTS AND ANALYSIS OF RESPONSE Haematologica Abstract Book, EHA Vienna, June 2015
92) Cerchione C, De Renzo A, Masarone M, Cimmino C, Persico M, Notarangelo M, Perna F, Mainolfi C, De Sio I, Ciancia G, Picardi M, Pane F MANAGEMENT OF PRIMARY HEPATIC NON HODGKIN’S LYMPHOMA AND CORRELATION WITH HCV INFECTION: EXCELLENT RESULTS WITH CONVENTIONAL CHEMOTHERAPY Haematologica Abstract Book, EHA Vienna, June 2015
93) Cerchione C, Catalano L, Pareto AE, Basile S, Marano L, Peluso I, Simeone L, Vitagliano O, Palmieri S, Rocco S, Ferrara F, Pane F BENDAMUSTINE IN THE MANAGEMENT OF RELAPSED AND REFRACTORY MULTIPLE MYELOMA: A REGIONAL REAL-LIFE EXPERIENCE
21
Haematologica Abstract Book, EHA Vienna, June 2015
94) Cerchione C, Catalano L, Pareto A.E., Basile S, Marano L, Peluso I, Simeone L, Vitagliano O, Palmieri S, Rocco S, Ferrara F, Pane F BENDAMUSTINE-BORTEZOMIB-DESAMETASONE (BVD) IN THE MANAGEMENT OF RELAPSED AND REFRACTORY MULTIPLE MYELOMA: A REGIONAL REAL-LIFE EXPERIENCE Leuk Res Vol 15, Suppl 3, September 2015
95) Cerchione C, Catalano L, Pareto A.E., Marano L, Basile S, Pane F PEGYLATED DOXORUBICINE, CYCLOPHOSPHAMIDE AND DEXAMETASONE (CED): A NEW OPPORTUNITY IN RELAPSED AND REFRACTORY MULTIPLE MYELOMA Leuk Res Vol 15, Suppl 3, September 2015
96) Cerchione C, De Renzo A, Cimmino C, Raimondo M, Marano L, Madonna E, Di Perna M, Russo V, Mainolfi C, Picardi M, Pane F BRENTUXIMAB VEDOTIN IN THE MANAGEMENT OF RELAPSED/REFRACTORY LYMPHOMA IN YOUNG PATIENTS: OUR REAL-LIFE EXPERIENCE Haematologica Abstract Book, Sie Firenze, October 2015
97) Cerchione C, Catalano L, Pareto AE, Basile S, Marano L, Peluso I, Simeone L, Vitagliano O, Palmieri S, Rocco S, Ferrara F, Pane F BENDAMUSTINE-BORTEZOMIB-DESAMETASONE (BVD) IN THE MANAGEMENT OF RELAPSED AND REFRACTORY MULTIPLE MYELOMA: A REGIONAL REAL-LIFE EXPERIENCE Haematologica Abstract Book, Sie Firenze, October 2015
98) Cerchione C, Vitagliano O, Simeone L, Pareto AE, Cerciello G, Soriente I, D’Arco AM, Danise P, Alfinito F, Pane F MANAGEMENT OF MYELODYSPLASTIC SYNDROMES WITH ERYTHROPOIESIS STIMULATING AGENTS (ESAs): EVALUATION OF ERYTHROPOIETIC ASPECTS AND ANALYSIS OF RESPONSE Haematologica Abstract Book, Sie Firenze, October 2015
99) Claudio Cerchione, Catalano L, Pareto AE, Marano L, Basile S, Pane F PEGYLATED LIPOSOMAL DOXORUBICIN, CYCLOPHOSPHAMIDE AND DEXAMETHASONE (CED): A NEW OPPORTUNITY IN RELAPLSED AND REFRACTORY MULTIPLE MYELOMA Haematologica Abstract Book, Sie Firenze, October 2015
100) Cerchione C, De Renzo A, Masarone M, Cimmino C, Raimondo M, Signoriello G, Notarangelo M, Giagnuolo G, Di Perna M, Russo V, Persico M, Pane F COST-EFFECTIVE ANALYSIS OF PROPHYLAXIS WITH LAMIVUDINE FOR PREVENTION OF REACRIVATION IN OCCULT HEPATITIS B IN PATIENTS WITH NON HODGKIN LYMPHOMA CD20+ UNDERGOING CHEMOTHERAPY Haematologica Abstract Book, Sie Firenze, October 2015
101) Cerchione C, De Renzo A, Masarone M, Cimmino C, Persico M, Notarangelo M, Perna F, Mainolfi C, De Sio I, Ciancia G, Picardi M, Pane F MANAGEMENT OF PRIMARY HEPATIC NON-HODGKIN’S LYMPHOMA (PHL) Haematologica Abstract Book, Sie Firenze, October 2015
102) Cerchione C, De Renzo A, Cimmino C, Raimondo M, Di Perna M, Russo V, Picardi M, Pane F PEGFILGRASTIM IN PRIMARY PROPHYLAXIS OF FEBRILE NEUTROPENIA DURING RITUXIMAB-BENDAMUSTINE TREATMENT IN INDOLENT NON HODGKIN LYMPHOMA: A REAL-LIFE EXPERIENCE Haematologica Abstract Book, Sie Firenze, October 2015
103) Cerchione C, Catalano L, Pareto AE, Basile S, Marano L, Peluso I, Simeone L, Vitagliano O, Palmieri S, Rocco S, Ferrara F, Pane F “Bendamustine-Bortezomib-Desametasone (BVD) in the management of Relapsed and Refractory Multiple Myeloma: A real-life experience” Blood December 3, 2015, 126 (23)
104) Cerchione C, De Renzo A, Masarone M, Cimmino C, Di Perna M, Signoriello G, Persico M, Pane F Lamivudine for prevention of reactivation in occult hepatitis B in patients with non-Hodgkin Lymphoma CD20+ undergoing chemotherapy: a cost-effective analysis Haematologica Abstract Book, EHA Copenaghen, June 2016
22
105) Cerchione C, Vitagliano O, Pareto AE, Di Perna M, Cerciello G, Soriente I, Alfinito F, Pane F Management of myelodysplastic syndromes with Erythropoiesis stimulating agents (ESAs): a real-life experience Haematologica Abstract Book, EHA Copenaghen, June 2016
106) Cerchione C, De Renzo A, Masarone M, Cimmino C, Della Pepa R, Di Perna M, Mainolfi C, De Sio I, Ciancia G, Persico M, Pane F Management of primary hepatic non-Hodgkin’s lymphoma (PHL) Haematologica Abstract Book, EHA Copenaghen, June 2016
107) Gravetti A, Cerchione C, Casoria A, Pugliese N, Marano L, De Gregorio F, Di Perna M, Picardi M, Martinelli V, Pane F Use of combined oral administration of analgesia and anxiolysis for pain associated with bone marrow aspiration and biopsy Haematologica Abstract Book, EHA Copenaghen, June 2016
108) De Nisco M, Cerchione C, Martinelli V, Pugliese N, Pedatella S, Catalano L, Manfra M, Marra N, Iula VD, Pagano F, Picardi M, Pane F An HPLC and 1H NMR study of the cytarabine degradation in clinical conditions to avoid drug waste, decrease therapy costs and improve patient compliance Haematologica Abstract Book, EHA Copenaghen, June 2016
109) Cerchione C, Catalano L, Pareto AE, Basile S, Marano L, Peluso I, Simeone L, Vitagliano O, Palmieri S, Ferrara F, Pane F Bendamustine-Bortezomib-Dexamethasone (BVD) in the management of relapsed and refractory multiple myeloma: a real-life experience Haematologica Abstract Book, EHA Copenaghen, June 2016
110) Cerchione C, De Renzo A, Cimmino C, Raimondo M, Di Perna M, Picardi M, Pane F Pegfilgrastim in primary prophylaxis of febrile neutropenia during rituximab-bendamustine treatment in indolent non Hodgkin lymphoma: a real-life experience Haematologica Abstract Book, EHA Copenaghen, June 2016
111) Cerchione C, Nappi D, Salvatore D, Migliaccio I, Pane F, Catalano L Pegfilgrastim versus filgrastim in the management of post-chemotherapy neutropenia in relapsed and refractory multiple myeloma in treatment with BVD (bendamustine-bortezomib-dexamethasone) Haematologica Abstract Book, EHA Copenaghen, June 2016
112) Cerchione C, Di Perna M, Della Pepa R, Pugliese N, Caprioli V, Frieri C, Pane F, Picardi M Front-line central vascular access devices in acute leukemias – peripherally inserted central catether (PICC) versus traditional central venous catether (CVC): a phase IV randomized trial (NCT02405728) Haematologica Abstract Book, EHA Copenaghen, June 2016
113) Cerchione C, Di Perna M, Pugliese N, Della Pepa R, Raimondo M, Pane F, Picardi M Bendamustine-brentuximab combination is effective and has a favourable toxicity profile in the treatment of refractory and relapsed Hodgkin lymphoma Haematologica Abstract Book, EHA Copenaghen, June 2016
114) Cerchione C, Catalano L, Pareto AE, Basile S, Peluso I, Marano L, Simeone L, Vitagliano O, Palmieri S, Rocco S, Ferrara F, Pane F Role of Bendamustine-bortezomib-dexamethasone (BVD) in the management of relapsed and refractory multiple myeloma: a real-life experience SIICA: Multiple Myeloma 2016 – Perspectives for a paradigm change – Catanzaro – June 2016
115) Cerchione C, Di Perna M, Della Pepa R, Pugliese N, Pane F, Picardi M Front-line central vascular access devices in acute leukemias – peripherally inserted central catether (PICC) versus traditional central venous catether (CVC): a phase IV randomized trial (NCT02405728) ASH meeting on hematologic malignancies, Chicago, September 2016
116) Cerchione C, Di Perna M, Della Pepa R, Pugliese N, Raimondo M, Pane F, Picardi M Bendamustine-brentuximab combination is effective and has a favourable toxicity profile in the treatment of refractory and relapsed Hodgkin lymphoma ASH meeting on hematologic malignancies, Chicago, September 2016
117) Cerchione C, Catalano L, Pareto AE, Basile S, Marano L, Peluso I, Simeone L, Vitagliano O, Palmieri S, Rocco S, Ferrara
23
F, Pane F Bendamustine-bortezomib-dexamethasone (BVD) in the management of relapsed and refractory multiple myeloma: a real-life experience ESH 3rd International Conference on Multiple Myeloma – Milan – October 2016 (Oral presentation)
118) Cerchione C, Di Perna M, Della Pepa R, Pugliese N, Raimondo M, Pane F, Picardi M Bendamustine-brentuximab combination is effective and has a favourable toxicity profile in the treatment of refractory and relapsed Hodgkin lymphoma Haematologica Abstract Book, SIES Rimini, October 2016
119) Cerchione C, Vitagliano O, Cerciello G, Pareto AE, Di Perna M, Soriente I, D’Arco AM, Danise P, Alfinito F, Pane F Management of myelodysplastic syndromes with Erythropoiesis stimulating agents (ESAs) : evalutation of erythropoietic aspects and analysis of response Haematologica Abstract Book, SIES Rimini, October 2016
120) Cerchione C, Luciano L, Cimmino C, Memoli M, Pane F Imatinib mesylate and cardiac function Haematologica Abstract Book, SIES Rimini, October 2016
121) Cerchione C, De Renzo A, Masarone M, Cimmino C, Persico M, Notarangelo M, Rosato V, Della Pepa R, Pugliese N,
Mainolfi C, De Sio I, Pane F, Picardi M Primary hepatic non Hodgkin lymphoma: high prevalence of hepatitis C virus infection and efficacy of the conventional six courses of anthracycline-based chemotherapy Haematologica Abstract Book, SIES Rimini, October 2016
122) Cerchione C, Di Perna M, Della Pepa R, Pugliese N, Caprioli V, Frieri C, Pane F, Picardi M Front-line central vascular access devices in acute leukemias – peripherally inserted central catether (PICC) versus traditional central venous catether (CVC): a phase IV randomized trial (NCT02405728) Haematologica Abstract Book, SIES Rimini, October 2016
123) Cerchione C, Gravetti A, Casoria A, Pugliese N, Marano L, Raimondo M, Picardi M, Martinelli V, Pane F Use of combined oral administration of analgesia and anxiolysis for pain associated with bone marrow aspiration and biopsy Haematologica Abstract Book, SIES Rimini, October 2016
124) De Nisco M, Cerchione C, Martinelli V, Pugliese N, Pedatella S, Catalano L, Manfra M, Marra N, Iula VD, Pagano F, Picardi M, Bolognese A, Pane F An HPLC and 1H NMR Study of the cytarabine degradation in clinical conditions to avoid drug waste, decrease therapy costs and improve patient compliance Haematologica Abstract Book, SIES Rimini, October 2016
125) Cerchione C, Catalano L, Pareto AE, Basile S, Marano L, Peluso I, Simeone L, Vitagliano O, Palmieri S, Rocco S, Ferrara F, Pane F Role of Bendamustine-Bortezomib-Dexamethasone (BVD) in the management of Relapsed and Refractory Multiple Myeloma: A real-life experience Haematologica Abstract Book, SIES Rimini, October 2016
126) Cerchione C, Catalano L, Peluso I, Nappi D, Di Perna M, Salvatore D, Migliaccio I, Picardi M, Pane F Managing neutropenia by pegfilgrastim in patients affected by relapsed/refractory multiple myeloma treated with Bendamustine-Bortezomib-Dexamethasone Haematologica Abstract Book, SIES Rimini, October 2016
127) Cerchione C, Di Perna M, Nappi D, Zacheo I, Pane F, Catalano L Lenalidomide twenty-five mg every other day in patients affected by multiple myeloma and renal failure Haematologica Abstract Book, SIES Rimini, October 2016
128) Pugliese N, Di Perna M, Cozzolino I, Ciancia G, Pettinato G, Varone V, Zeppa P, Masone S, Cerchione C, Della Pepa R,
Salvatore C, Pane F, Picardi M Randomized Comparison of Power Doppler Ultrasonography-Guided-Core-Needle Biopsy with Open Surgical Biopsy for the Characterization of Lymphadenopathies in patients with suspected lymphoma Blood 2016 128: 685 (ASH 2016 Abstract Book)
24
129) Cerchione C, Di Perna M, Nappi D, Zacheo I, Pane F, Catalano L Bendamustine-bortezomib-dexamethasone (BVD) in the management of relapsed and refractory multiple myeloma: a real-life experience 16TH International Myeloma Workshop 2017, New Delhi, India
130) Cerchione C, Di Perna M, Nappi D, Zacheo I, Pane F, Catalano L Lenalidomide at the dose of twenty-five mg every other day in patients affected by multiple myeloma and renal failure: a real-life experience 16TH International Myeloma Workshop 2017, New Delhi, India
131) Cerchione C, Vitagliano O, Cerciello G, Pareto AE, Di Perna M, Soriente I, D’Arco AM, Danise P, Alfinito F, Pane F Management of myelodysplastic syndromes with erythropoiesis stimulating agents (ESAs) in real-life experience: an update from RECAMDS Leuk Res Abstract Book, 14TH International Symposium on Myelodysplastic Syndromes (MDS 2017), Valencia, May 2017
132) Cerchione C, Di Perna M, Della Pepa R, Pugliese N, Pane F, Picardi M High-dose bendamustine plus brentuximab combination is effective and has a favourable toxicity profile in the treatment of refractory and relapsed Hodgkin lymphoma 14TH International Conference on Malignant Lymphoma, Lugano, June 2017
133) Cerchione C, Di Perna M, Della Pepa R, Pugliese N, Pane F, Picardi M Front-line vascular access devices in acute leukemias – peripherally inserted central catheter (PICC) versus traditional center venous catheter (CVC): a phase IV randomized trial (NCT02405728) Oral communication - Haematologica Abstract Book, EHA Madrid, June 2017
134) Cerchione C, Catalano L, Pareto AE, Basile S, Marano L, Marano L, Peluso I, Simeone L, Vitalgiano O, Palmieri S, Rocco S, Ferrara F, Pane F Bendamustine-bortezomib-dexamethasone (BVD) in the management of relapsed and refractory multiple myeloma: a real-life experience Haematologica Abstract Book, EHA Madrid, June 2017
135) Della Pepa R, Picardi M, Giordano C, Zacheo I, Pugliese N, Cerchione C, Pane F Nodular lymphocyte predominant Hodgkin lymphoma: a new risk adapted treatment strategy based on Rituximab Haematologica Abstract Book, EHA Madrid, June 2017
136) Cerchione C, Catalano L, Pareto AE, Nappi D, Peluso I, Ferrara K, Di Perna M, Zacheo I, Pane F Lenalidomide at the dose of twenty-five mg every other day in patients affected by multiple myeloma and renal failure: a real-life experience Haematologica Abstract Book, EHA Madrid, June 2017
137) Cerchione C, Picardi M, Pugliese N, Della Pepa R, Gravetti A, Casoria A, Catalano L, Nappi D, Ciancia G, Pettinato G, Pane F, Martinelli V Use of combined oral fentanyl citrate (Actiq) and midazolam as premedication for bone marrow biopsy in patients with hematological malignancies: a randomized controlled patient blinded clinical trial Haematologica Abstract Book, EHA Madrid, June 2017
138) Cerchione C, Vitagliano O, Cerciello G, Pareto AE, Di Perna M, Soriente I, D’Arco AM, Danise P, Alfinito F, Pane F Management of myelodysplastic syndromes with erythropoiesis stimulating agents (ESAs) in real-life experience: an update from RECAMDS Haematologica Abstract Book, EHA Madrid, June 2017
139) Puglese N, Simeone L, Della Pepa R, Giordano C, Cappuccio I, Zacheo I, Campagna G, Cerchione C, Zeppa P, Salvatore C, Pane F, Picardi M Impact on survival of early detection of recurrence in the follow-up of high risk Hodgkin lymphoma in first complete remission Haematologica Abstract Book, EHA Madrid, June 2017
140) Cerchione C, Di Perna M, Della Pepa R, Pugliese N, Pane F, Picardi M High-dose bendamustine plus brentuximab combination is effective and has a favourable toxicity profile in the treatment of refractory and relapsed Hodgkin lymphoma Haematologica Abstract Book, EHA Madrid, June 2017
25
141) Cerchione C, Ferrara K, Peluso I, Nappi D, Di Perna M, Zacheo I, Pareto AE, Pane F, Catalano L Carfilzomib-lenalidomide-dexamethasone in the management of relapsed and refractory multiple myeloma: a real-life experience Haematologica Abstract Book, EHA Madrid, June 2017
142) Cerchione C, Catalano L, Pareto AE, Nappi D, Peluso I, Ferrara K, Di Perna M, Zacheo I, Romano A, Pane F Full standard doses of lenalidomide in bortezomib-refractory Multiple Myeloma patients affected by renal failure: a real-life experience Clinical Myeloma & Lymphoma, Vol. 17, Suppl. 2, September 2017
143) Cerchione C, Catalano L, Pareto AE, Basile S, Marano L, Peluso I, Simeone L, Vitagliano O, Palmieri S, Rocco S, Romano A, Ferrara F, Pane F Bendamustine-Bortezomib-Dexamethasone (BVD) in the management of Relapsed and Refractory Multiple Myeloma: A Real-Life Experience Clinical Myeloma & Lymphoma, Vol. 17, Suppl. 2, September 2017
144) Cerchione C, Ferrara K, Peluso I, Nappi D, Di Perna M, Zacheo I, Pareto AE, Pane F, Catalano L Front-line vascular access devices in acute leukemias – Peripherally Inserted Central Catheter (PICC) versus traditional Central Venous Catether (CVC): A Phase IV Randomized Trial (NCT02405728) Clinical Myeloma & Lymphoma, Vol. 17, Suppl. 2, September 2017
145) Cerchione C, Picardi M, Di Perna M, Della Pepa R, Pugliese N, Pane F
Front-line vascular access devices in acute leukemias – peripherally inserted central catheter (PICC) versus traditional center venous catheter (CVC): a phase IV randomized trial (NCT02405728) Oral communication - Haematologica Abstract Book, SIE Roma, October 2017
146) Palmieri S, Rocco S, Migliaccio I, Cerchione C, Catalano L, Ferrara K, Peluso I, Monaco G, Farina G, Gagliardi A, Barone
M, Esposito D, Amico V, Arcamone M, Fontana R, Sica A, Pane F, Ferrara F KRD (Carfilzomib plus Lenalidomide plus Dexamethasone) in relapsed or refractory Multiple Myeloma in Campania Region: a one-year survey Haematologica Abstract Book, SIE Roma, October 2017
147) Cerchione C, Picardi M, Pugliese N, Della Pepa R, Cappuccio I, Campagna G, Fanelli F, Gravetti A, Casoria A, Catalano L, Nappi D, Ciancia G, Pettinato G, Pane F, Martinelli V Use of combined oral administration of analgesia and anxiolysis for pain associated with bone marrow aspiration and biopsy Haematologica Abstract Book, SIE Roma, October 2017
148) Cerchione C, Catalano L, Pareto AE, Basile S, Marano L, Peluso I, Simeone L, Vitagliano O, Palmieri S, Rocco S, Romano A, Ferrara F, Pane F Bendamustine-Bortezomib-Dexamethasone (BVD) in the management of Relapsed and Refractory Multiple Myeloma: A Real-Life Experience Haematologica Abstract Book, SIE Roma, October 2017
149) Della Pepa R, Picardi M, Giordano C, Zacheo I, Pugliese N, Cerchione C, Pane F Nodular lymphocyte predominant Hodgkin lymphoma: a new risk adapted treatment strategy based on Rituximab Haematologica Abstract Book, SIE Roma, October 2017
150) Cerchione C, Picardi M, Di Perna M, Della Pepa R, Pugliese N, Della Pepa R, Pane F High-dose bendamustine plus brentuximab vedotin is effective and has a favourable toxicity profile in the treatment of refractory or relapsed Hodgkin lymphoma Haematologica Abstract Book, SIE Roma, October 2017
151) Cerchione C, Ferrara K, Peluso I, Di Perna M, Zacheo I, Nappi D, Pareto A. E., Pane F, Catalano L Carfilzomib-lenalidomide-dexamethasone in the management of lenalidomide-refractory multiple myeloma: a real-life experience Haematologica Abstract Book, SIE Roma, October 2017
152) Cerchione C, Catalano L, Pareto AE, Nappi D, Peluso I, Ferrara K, Di Perna M, Zacheo I, Pane F Lenalidomide at the dose of twenty-five mg every other day in patients affected by multiple myeloma and renal failure: a real-life experience Haematologica Abstract Book, SIE Roma, October 2017
26
153) Cerchione C, Vitagliano O, Cerciello G, Pareto AE, Di Perna M, Soriente I, D’Arco AM, Danise P, Alfinito F, Pane F
Management of low-risk myelodysplastic syndromes with erythropoiesis stimulating agents (ESAs) in real-life experience: an update from RECAMDS (Registro Campano delle sindromi mielodisplastiche) Haematologica Abstract Book, SIE Roma, October 2017
154) Puglese N, Simeone L, Della Pepa R, Giordano C, Cappuccio I, Zacheo I, Campagna G, Cerchione C, Zeppa P, Salvatore C, Pane F, Picardi M Impact on survival of early detection of recurrence in the follow-up of high risk Hodgkin lymphoma in first complete remission Haematologica Abstract Book, SIE Roma, October 2017
155) Cerchione C, Di Perna M, Della Pepa R, Pugliese N, Pane F, Picardi M Pomalidomide-dexamethasone in the management of heavily pretreated multiple myeloma Haematologica Abstract Book, SIE Roma, October 2017
156) Cerchione C, Ferrara K, Peluso I, Nappi D, Di Perna M, Zacheo I, Pareto AE, Pane F, Catalano L Bortezomib, lenalidomide and dexamethasone in the management of relapsed and refractory multiple myeloma: a real-life experience Haematologica Abstract Book, SIE Roma, October 2017
157) Cerchione C, Picardi M, Pugliese N, Della Pepa R, Gravetti A, Casoria A, Nappi D, Ciancia G, Pane F, Martinelli V Combined oral fentanyl citrate (Actiq) and midazolam as premedication for bone marrow aspiration and biopsy in patients with hematological malignancies: a randomized, controlled clinical trial VII Corso di Alta Formazione in terapia del dolore, Abstract Book, Capri (NA); October 2017
158) Cerchione C, Nappi D, Pareto AE, Romano A, Di Perna M, Zacheo I, Picardi M, Pane F, Catalano L Safety and comfort of domestic bortezomib injection in real-life experience Blood December 2017 (ASH 2017 Abstract Book)
159) Cerchione C, Di Perna M, Pugliese N, Della Pepa R, Pane M, Picardi M
High-dose bendamustine plus brentuximab combination is effective and has a favourable toxicity profile in the treatment of refractory and relapsed Hodgkin lymphoma Blood December 2017 (ASH 2017 Abstract Book)
160) Cerchione C, Picardi M, Pugliese N, Della Pepa R, Gravetti A, Casoria A, Nappi D, Ciancia G, Pane F, Martinelli V Combined oral administration of analgesia and anxiolysis for pain associated with bone marrow aspiration and biopsy Blood December 2017 (ASH 2017 Abstract Book)
161) Palmieri S, Rocco S, Migliaccio I, Cerchione C, Catalano L, Ferrara K, Peluso I, Monaco G, Farina G, Gagliardi A, Barone M, Esposito D, Amico V, Arcamone M, Fontana R, Sementa A, Sica A, Svanera G, Pane F, Ferrara F KRD (Carfilzomib plus lenalidomide plus dexamethasone) in relapsed or refractory multiple myeloma: a real life survey in Campania region in southern Italy Haematologica Abstract Book, EMN Turin, April 2018, s1
162) Cerchione C, Catalano L, Pareto AE, Basile S, Marano L, Peluso I, Simeone L, Vitagliano O, Romano A, Palmieri S, Rocco S, Monaco G, Romano A, Pane F, Ferrara F Bendamustine-Bortezomib-Dexamethasone (BVD) in heavily pretreated Multiple Myeloma Haematologica Abstract Book, EMN Turin, April 2018, s1
163) Cerchione C, Ferrara K, Peluso I, Di Perna M, Zacheo I, Nappi D, Pareto A. E., Pane F, Catalano L Carfilzomib-lenalidomide-dexamethasone in the management of lenalidomide-refractory multiple myeloma Haematologica Abstract Book, EMN Turin, April 2018, s1
164) Cerchione C, Nappi D, Pareto AE, Migliaccio I, Zacheo I, Di Perna M, Peluso I, Ferrara K, Pane F, Catalano L.
Pomalidomide-dexamethasone in the management of heavily pretreated multiple myeloma Haematologica Abstract Book, EMN Turin, April 2018, s1
165) Cerchione C, Pareto AE, Zacheo I, Di Perna M, Nappi D, Peluso I, Ferrara K, Romano A, Pane F, Catalano L Bortezomib, lenalidomide and dexamethasone in the management of relapsed and refractory multiple myeloma: a real-life experience
27
Haematologica Abstract Book, EMN Turin, April 2018, s1
166) Cerchione C, Nappi D, Pareto AE, Romano A, Di Perna M, Zacheo I, Picardi M, Pane F, Catalano L Safety and comfort of domestic bortezomib injection in real-life experience Haematologica Abstract Book, EMN Turin, April 2018, s1
167) Pugliese N, Giordano C, Nappi D, Luciano L, Cerchione C, Annunziata M, Casale B, Crisà E, Villa MR, Pezzullo L, Iovine M, Picardi M, Simeone L, Pane F, Martinelli V Ruxolitinib and hydroxyurea combination for the treatment of myelofibrosis HemaSphere Abstract Book, EHA Stockholm, June 2018, 2 (S1)
168) Raimondo M, Della Pepa R, Giordano C, Pugliese N. Cerchione C, Trastulli F, Mortaruolo C, Zacheo I, Picardi M, Pane F Efficacy and safety of high dose bendamustine plus brentuximab vedotin in refractory or relapsed classical Hodgkin lymphoma: a single center experience HemaSphere Abstract Book, EHA Stockholm, June 2018, 2 (S1)
169) Cerchione C, Catalano L, Pareto AE, Basile S, Marano L, Peluso I, Simeone L, Vitagliano O, Palmieri S, Rocco S, Monaco G, Romano A, Pane F, Ferrara F Bendamustine-Bortezomib-Dexamethasone (BVD) in heavily pretreated Multiple Myeloma HemaSphere Abstract Book, EHA Stockholm, June 2018, 2 (S1)
170) Cerchione C, Ferrara K, Peluso I, Di Perna M, Zacheo I, Nappi D, Pareto A. E., Romano A, Pane F, Catalano L Carfilzomib-lenalidomide-dexamethasone in the management of lenalidomide-refractory multiple myeloma HemaSphere Abstract Book, EHA Stockholm, June 2018, 2 (S1)
171) Cerchione C, Pareto AE, Zacheo I, Di Perna M, Nappi D, Peluso I, Ferrara K, Romano A, Pane F, Catalano L Bortezomib, lenalidomide and dexamethasone in the management of relapsed and refractory multiple myeloma: a real-life experience HemaSphere Abstract Book, EHA Stockholm, June 2018, 2 (S1)
172) Cerchione C, Nappi D, Pareto AE, Migliaccio I, Zacheo I, Di Perna M, Peluso I, Ferrara K, Romano A, Pane F, Catalano L. Pomalidomide-dexamethasone in the management of heavily pretreated multiple myeloma HemaSphere Abstract Book, EHA Stockholm, June 2018, 2 (S1)
173) Cerchione C, Picardi M, Pugliese N, Della Pepa R, Gravetti A, Casoria A, Nappi D, Ciancia G, Pettinato G, Pane F, Martinelli V Combined oral administration of analgesia and anxiolysis for pain associated with bone marrow aspiration and biopsy HemaSphere Abstract Book, EHA Stockholm, June 2018, 2 (S1)
174) Cerchione C, Catalano L, Nappi D, Pareto AE, Basile S, Marano L, Peluso I, Simeone L, Vitagliano O, Palmieri S, Rocco S, Romano A, Ferrara F, Pane F Bendamustine-Bortezomib-Dexamethasone in Heavily Pretreated Multiple Myeloma Clinical Myeloma & Lymphoma, Vol. 18, Suppl. 1, September 2018
175) Cerchione C, Ferrara K, Peluso I, Di Perna M, Zacheo I, Nappi D, Pareto A. E., Pane F, Catalano L Carfilzomib-lenalidomide-dexamethasone in the management of lenalidomide-refractory multiple myeloma Clinical Myeloma & Lymphoma, Vol. 18, Suppl. 1, September 2018
176) Cerchione C, Nappi D, Pareto AE, Migliaccio I, Zacheo I, Di Perna M, Peluso I, Ferrara K, Romano A, Pane F, Catalano L. Pomalidomide-dexamethasone in the management of heavily pretreated multiple myeloma Clinical Myeloma & Lymphoma, Vol. 18, Suppl. 1, September 2018
177) Cerchione C, Nappi D, Pareto AE, Picardi M, Pane F, Catalano L. Pegfilgrastim versus filgrastim in the management of therapy-related neutropenia in relapsed and refractory multiple myeloma in treatment with pomalidomide-dexamethasone Clinical Myeloma & Lymphoma, Vol. 18, Suppl. 1, September 2018
178) Cerchione C, Picardi M, Pugliese N, Della Pepa R, Gravetti A, Casoria A, Nappi D, Ciancia G, Pane F, Martinelli V Combined oral administration of analgesia and anxiolysis for pain associated with bone marrow aspiration and biopsy Clinical Myeloma & Lymphoma, Vol. 18, Suppl. 1, September 2018
28
179) Cerchione C, Ferrara K, Peluso I, Di Perna M, Zacheo I, Nappi D, Pareto A. E., Romano A, Pane F, Catalano L
Carfilzomib-lenalidomide-dexamethasone in the management of lenalidomide-refractory multiple myeloma ESH 4rd International Conference on Multiple Myeloma – Mandelieu, France – October 2018
180) Cerchione C, Nappi D, Pareto AE, Migliaccio I, Zacheo I, Di Perna M, Peluso I, Ferrara K, Romano A, Pane F, Catalano L. Pomalidomide-dexamethasone in the management of heavily pretreated multiple myeloma ESH 4rd International Conference on Multiple Myeloma – Mandelieu, France – October 2018
181) Cerchione C, Nappi D, Pareto AE, Picardi M, Pane F, Catalano L. Pegfilgrastim versus filgrastim in the management of therapy-related neutropenia in relapsed and refractory multiple myeloma in treatment with pomalidomide-dexamethasone ESH 4rd International Conference on Multiple Myeloma – Mandelieu, France – October 2018
182) Cerchione C, Pareto AE, Zacheo I, Di Perna M, Nappi D, Peluso I, Ferrara K, Romano A, Pane F, Catalano L
Bortezomib, lenalidomide and dexamethasone in the management of relapsed and refractory multiple myeloma: a real-life experience ESH 4rd International Conference on Multiple Myeloma – Mandelieu, France – October 2018
183) Cerchione C, Ferrara K, Peluso I, Di Perna M, Zacheo I, Nappi D, Pareto A. E., Romano A, Pane F, Catalano L Carfilzomib-lenalidomide-dexamethasone in the management of lenalidomide-refractory multiple myeloma Hematology Abstract Book, SIES, October 2018 (Suppl. 2)
184) Cerchione C, Nappi D, Pareto AE, Migliaccio I, Zacheo I, Di Perna M, Peluso I, Ferrara K, Romano A, Pane F, Catalano L. Pomalidomide-dexamethasone in the management of heavily pretreated multiple myeloma Hematology Abstract Book, SIES, October 2018 (Suppl. 2)
185) Cerchione C, Picardi M, Pugliese N, Della Pepa R, Gravetti A, Casoria A, Nappi D, Ciancia G, Pane F, Martinelli V Combined oral administration of analgesia and anxiolysis for pain associated with bone marrow aspiration and biopsy Hematology Abstract Book, SIES, October 2018 (Suppl. 2) – Oral communication
186) Cerchione C, Nappi D, Pareto AE, Picardi M, Pane F, Catalano L. Pegfilgrastim versus filgrastim in the management of therapy-related neutropenia in relapsed and refractory multiple myeloma in treatment with pomalidomide-dexamethasone Hematology Abstract Book, SIES, October 2018 (Suppl. 2)
187) Cerchione C, Catalano L, Pareto AE, Basile S, Marano L, Peluso I, Simeone L, Vitagliano O, Palmieri S, Rocco S, Monaco G, Romano A, Pane F, Ferrara F Bendamustine-Bortezomib-Dexamethasone (BVD) in heavily pretreated Multiple Myeloma Hematology Abstract Book, SIES, October 2018 (Suppl. 2)
188) Cerchione C, Pareto AE, Zacheo I, Di Perna M, Nappi D, Peluso I, Ferrara K, Romano A, Pane F, Catalano L Bortezomib, lenalidomide and dexamethasone in the management of relapsed and refractory multiple myeloma: a real-life experience Hematology Abstract Book, SIES, October 2018 (Suppl. 2)
189) Cerchione C, Nappi D, Pareto AE, Migliaccio I, Zacheo I, Di Perna M, Peluso I, Ferrara K, Romano A, Pane F, Catalano L.
Pomalidomide-dexamethasone in the management of heavily pretreated multiple myeloma Blood December 2018 (ASH 2018 Abstract Book)
190) Cerchione C, Nappi D, Pareto AE, Picardi M, Pane F, Catalano L. Pegfilgrastim versus filgrastim in the management of therapy-related neutropenia in relapsed and refractory multiple myeloma in treatment with pomalidomide-dexamethasone Blood December 2018 (ASH 2018 Abstract Book)
29
CONFERENCES AND TRAINING
COURSES
2 April 2004
10 March 2007
21 September 2007
22 September 2007
30 November – 1 December 2007
5-6 December 2007
4 April 2008
29 April 2008
20 September 2008
24 October 2008
19 December 2008
20 February 2009
13-14 March 2009
16-20 March 2009
25 March 2009
26 June 2009
30 June 2009
16 September 2009
22 September 2009
Oncologia: Problematiche e Attualità (Aula magna Policlinico Federico II) Terapie innovative in Ematologia (Grand Hotel's Parker's, Napoli) Seminario AIL pazienti Mieloma (Aula magna Policlinico Federico II) Seminario AIL pazienti Linfomi (Aula magna Policlinico Federico II) Mieloma Multiplo e Leucemia Linfatica Cronica: dalla biologia alla terapia (Grand Hotel's Parker's, Napoli) Congresso Nazionale “L'errore in medicina: prevenzione e gestione delle conseguenze” (Aula magna Policlinico Federico II) Sei anni di Imatinib: stato dell'arte e le esperienze campane (Aula Mediterraneo Ospedale Cardarelli) Update sulle Cardiopatie Infettive (Azienda Ospedaliera Cotugno) Meeting Educazionale in tema di Trombocitemia Essenziale (Grand Hotel Santa Lucia, Napoli) Reuniao sobre Linfomas Indolentes, Sociedade Portuguesa de Hematologia, speaker prof. Robert Marcus (Hotel Mirage Cascais – Lisbona, Portogallo) Highlights nelle leucemie Ph+ (Holiday Inn Napoli) Philadelphia positive Leukemias: Update e Subjective experiences (Hotel Gli Dei, Pozzuoli- Napoli) Aggiornamenti in Ematologia: Mieloma Multiplo – Verso la guarigione? (Accademia Aeronautica Militare, Pozzuoli – Napoli) Partecipazione con Borsa di studio all’8° Corso di Formazione avanzata “Cellule Staminali e medicina rigenerativa 2009: Attualità e prospettive” (Collegio Ghislieri, Pavia) Meeting di aggiornamento in Ematologia Sperimentale “Piernicola Boccuni” (CEINGE, Napoli) La gestione dell’Emoglobinuria Parossistica Notturna: ultimi sviluppi nella diagnosi e nel trattamento (Hotel Royal Continental, Napoli) II Stage Campano “Diagnosi e Terapia dei Linfomi” (CEINGE, Napoli) CML Discussion Board: Management della LMC nel 2009: dalla ricerca alla pratica clinica (CEINGE, Napoli) Le Leucemie Ph+ nell’era dei TKI (Holiday Inn, Napoli)
30
18,19,20,21 October 2009
29-30-31 OCTOBER – 1
NOVEMBER 2009
13-14 November 2009
24 November 2009
26 November 2009
42°Congresso Nazionale SIE (Società Italiana di Ematologia) (Milano Convention Centre, Milano) 5th Nilotinib Global Investigator Meeting (Istanbul, Turkey) Corso di Aggiornamento: La Leucemia Linfatica Cronica. Come curarla Mieloma multiplo: cosa è cambiato. Confronto con gli esperti. (Hotel Royal Continental, Napoli) III Stage Campano “Diagnosi e Terapia dei Linfomi” (CEINGE, Napoli) Profilassi sulle infezioni fungine invasive nel paziente ematologico a rischio (Schering-Plough, Ospedale Cardarelli, Napoli) Alghoritm Plus: Philadelphia positive Leukemias: Update and subjective experiences Aggiornamenti in Ematologia: Le sindromi mielodisplastiche: come la biologia orienta le nuove strategie terapeutiche Stage in Ematologia: InHospital Meeting (Bristol-Myers Squibb, CEINGE, Napoli) Stage in Ematologia: Biologia, Clinica e Terapia della leucemia linfatica cronica (Golden Tulip Aemilia Hotel, Policlinico “S. Orsola-Malpighi”, Bologna) LightClub: Corso di Educazione Continua in Medicina: Workshop sulla Leucemia Mieloide Cronica (Novartis, Spineto) Partecipazione con Borsa di studio al 9° Corso di Formazione avanzata “Cellule Staminali: il vero bersaglio nella cura dei tumori” (Collegio Ghislieri, Pavia) CML Educational Meeting: “The Management of CML: current treatment paradigms and future perspectives” (Novartis Oncology, European Treatment and Outcome Study and LeukemiaNet, Hotel Royal Continental, Napoli) Appropriatezza e linee guida nelle terapie di supporto in Oncologia (Italfarmaco, A.O.R.N. Cardarelli, Napoli) Convegno AIL, Sezione di Caserta “Valentina Picazio” Ruolo strategico delle donazioni di cellule staminali da midollo osseo, da sangue cordonale e da sangue periferico, nella cura delle malattie oncoematologiche (Crown Plaza Hotel, Caserta) XI Congresso Nazionale SIES (Società Italiana di Ematologia Sperimentale), Torino
31
19-20 FEBRUARY 2010
26-27 FEBRUARY 2010
10-11 MARCH 2010 15,16 e 17 March 2010
9-10 APRIL 2010
19-23 April 2010 17-18 MAY 2010 25 JUNE 2010
2 OCTOBER 2010
6-7-8 OCTOBER 2010 19 OCTOBER 2010 28-29 OCTOBER 2010 28-29 OCTOBER 2010 4 NOVEMBER 2010
5 -6 NOVEMBER 2010
Le Leucemie Ph+ nell’era dei TKI (second edition) (Holiday Inn, Napoli) MASTERCLASS in Ematologia 2010 – Cavalcando alcuni argomenti in attesa di risposta (Responsabile Scientifico Prof.Sante Tura - Hotel Dino – Baveno (VB)) RELATORE alla Riunione Annuale dei Centri di Ematologia Meridionale ed Insulare (SIE SUD) con 2 COMUNICAZIONI ORALI (Resp Scientifico Prof Patrizio Mazza, Castellaneta Marina – Taranto) IV Stage Campano “Diagnosi e Terapia dei Linfomi” (CEINGE – Napoli) Le Emorragie della donna in età fertile : tra fisiologia e patologie dell’emostasi (Hotel dei congressi, Castellammare di Stabia) Corso di Aggiornamento: Appropriatezza nell’utilizzo dei nuovi farmaci in ematologia: evidenze cliniche e confronto (Hotel Excelsior – Napoli) Corso Nazionale di Aggiornamento SIE in Ematologia Clinica (Pescara, Auditorium De Cecco, presidenti prof. Tura e prof. Mandelli) Decisional Pathway in CML plus: Philadelphia positive Leukemias : Update and Subjective experiences (Hotel degli Dei – Agnano (Napoli) Leucemie Acute: dal genoma al fenotipo. Basi per una “Target-Tailored Therapy” (Accademia Aeronautica di Pozzuoli – Napoli) Blood Cancer in the Elderly – European Expert Forum (Marriot Park Convention Centre – Roma) La cura globale del soggetto affetto da emoglobinopatia (Direttore: Maria Domenica Cappellini – Accademia Nazionale di Medicina – Sezione di Ematologia –Milano) Partecipazione con Borsa di studio al 10° Corso di Formazione avanzata “Ricerca traslazionale in ematologia/oncologia” (Collegio Ghislieri, Pavia) MdsDoc – Myelodysplastic Syndrome Documentation – Best practice in the treatment with hypomethylating agents (CEINGE – Napoli) Training su “GCP e aspetti nella qualità di conduzione degli studi clinici” (Napoli – Policlinico Federico II) 2nd Update on Psoriatic Disease (Congress Center “Federico II”) Mieloma Multiplo: Highlights from the International Myeloma Workshop (Castel dell’Ovo – Napoli)
32
19-20 NOVEMBER 2010
22-23 NOVEMBER 2010 4 FEBRUARY 2011 4-5 MARCH 2011
19-20 MARCH 2011
29-30 APRIL 2011
16-20 May 2011
23 MAY 2011
15 June 2011
6-7 JULY 2011
7-8 JULY 2011
16-17-18-19 OCTOBER 2011
10-11-12-13 DECEMBER 2011
9-10 MARCH 2012
23 March 2012
16-20 April 2012
43 Congresso Nazionale SIE (Napoli – Mostra d’Oltremare) 53th American Society of Hematology - ASH Annual Meeting and Exposition (San Diego – California, USA) Il Linfoma di Hodgkin: Siamo alla svolta finale? (Accademia Aeronautica di Pozzuoli – Napoli) Il Linfoma Mantellare: la partita è in corso (Firenze) Partecipazione con Borsa di studio al 11° Corso di Formazione avanzata “Medicina genomica e terapia personalizzata in ematologia/oncologia” (Collegio Ghislieri, Pavia) Digital Workshop in CML 2012 (Napoli) Workshop sulla Leucemia Mieloide Cronica (Abbazia di Spineto, Sarteano (SI) Vfend-Day, il futuro è già successo (MAXXI Museo nazionale delle arti del XXI Secolo, Roma) Denosumab EU Investigator Meeting Study 20090482 (Vienna, Austria) XII Congresso Nazionale SIES (Società Italiana di Ematologia Sperimentale), Roma 54th American Society of Hematology - ASH Annual Meeting and Exposition (Atlanta, USA) Multiple Myeloma Debates – Recent Advances in Multiple Myeloma featuring Educational Updates from ASH 2012 (Berlin, Germany) Partecipazione con Borsa di studio al 12° Corso di Formazione avanzata “Le nicchie delle cellule staminali somatiche normali e tumorali” (Collegio Ghislieri, Pavia) I Biosimilari nel 2013: appropriatezza e sostenibilità economica (Aula Conferenze Seconda Università di Napoli) IV Giornate Ematologiche Irpine (Aula Magna Città Ospedaliera di Avellino) 18th EHA (European Hematology Association) (Stoccolma - Svezia) Rapid Fire in Hematology (Napoli) Open questions in Hematology (Napoli)
33
23 April 2012
25 – 26 May 2012
28 February, 1 March 2013
12 October 2012
17-19 October 2012
8-9-10-11 DECEMBER 2012
31 January, 1 February
2013
15-19 April 2013
25 JUNE 2013
21/22 JUNE 2013
12-16 JUNE 2013
4 JULY 2013
24 SEPTEMBER 2013
28 SEPTEMBER 2013
20 OCTOBER 2013
20 – 21 – 22 – 23 OCTOBER
2013
4-5-6 November 2013
15-16 NOVEMBER 2013
Una terapia sempre più mirata nel linfoma di Hodgkin e nei linfomi di derivazione T-linfocitaria (Hotel Royal, Napoli) Riunione GIMEMA Working Party Mieloma Multiplo (Verona) 44 Congresso Nazionale SIE (Verona) “Brain training in Hematology: Casi clinici “stimolanti” e “allocuzioni” lungimiranti (Evento SIE, Pesaro) iAcademy 2013 (Congresso Europeo di Infettivologia, Barcellona) iAcademy 2013 Italia (Vincitore di iAcademy Award 2013, Napoli) V Stage Campano “Diagnosi e Terapia dei Linfomi” (CEINGE – Napoli) Progressi nel trattamento dei linfomi (Hotel Baglioni, Firenze) Post New Orleans 2013 (Hotel Royal Continental Napoli) Il linfoma mantellare refrattario/recidivante (Starhotels Excelsior, Bologna) Relatore nella Tavola Rotonda Ruolo della Bendamustina nel paziente con Mieloma Multiplo Recidivato e Refrattario (AOU Federico II, Napoli) 19° congresso EHA (Milano) European Hematology Academy – Module II – Lymphoma and Multiple Myeloma (Amsterdam) Relatore in Italian Red Cell Club 2014 (San Marcellino e Festo, Napoli) XIII Congresso Nazionale SIES (Palacongressi Rimini) ELN Meeting Frontiers (Berlino, Germany) Relatore in Advisory Board: Appropriatezza di utilizzo di Bendamustina nel Mieloma Multiplo (CEINGE, Napoli) Corso Innovazioni in Ematologia (Alexander Museum Hotel, Pesaro) L’innovazione in ematologia e il ruolo dei policy makers (Biblioteca del Senato, Roma) iAcademy 2014 Italia (Vincitore di iAcademy Award 2014, Avellino)
34
22 NOVEMBER 2013
26 NOVEMBER 2013
27 JANUARY 2014
6-8 FEBRUARY 2014
4 MARCH 2014
3 APRIL 2014
11-15 JUNE 2014
12-13 SEPTEMBER 2014
3-4 OCTOBER 2014
15-17 OCTOBER 2014
16-19 OCTOBER 2014
28 OTTOBRE 2014
3-5 NOVEMBER 2014
19 NOVEMBER 2014
27 NOVEMBER 2014
28-29 NOVEMBER 2014
22-23 JANUARY 2015
12-13-14 FEBRUARY 2015
25 FEBRUARY 2015
2 MARCH 2015
9-11 MARCH 2015
Advanced ITP Discussion – AID Project (Renaissance Hotel Mediterraneo, Napoli) Hematology Debate 2015 (Hotel Diagonal Mar, Barcellona, Spain) Post-San Francisco 2014 (Palazzo della Gran Guardia, Verona) Corso Mission Hematology (Centro Cell, Padova) Relatore in Lo Sportello Giovani dell’Ordine dei Medici di Napoli incontra i Medici in Formazione 2014/2015 (Policlinico AOU Federico II, Napoli) Preceptorship Barcellona Multiple Myeloma (Hospital Clinic IDIBAPS Barcelona, Spain, Responsible prof Blade) Stage “Mieloma Multiplo” (Hotel Michelangelo, Milano) ComuniCARE LMC – Le parole che curano (Dynamo Camp, Limestre, Pistoia) MDS 2015 – The 13th International Symposium on Myelodysplastic Syndromes (Washington DC, USA) Bosulif Virtual Meeting L’immuno-oncologia nel trattamento del cancro: innovazione e nuova metodologia di valutazione degli outcomes (Hotel NH Vittorio Veneto, Roma) DynamoCamp – Formazione staff medico-infermieristico (Dynamo Camp, Limestre, Pistoia) 20° EHA (Vienna, Austria) 15th International Myeloma Workshop (Rome, Auditorium Parco della Musica) 45° Congresso Nazionale SIE (Firenze) Ematologia nel 2015: come sta cambiando la musica (Alexander Museum Palace Hotel, Pesaro) 57th American Society of Hematology - ASH Annual Meeting and Exposition (Orlando, USA) Nuove prospettive della diagnostica per immagini nei linfomi (SDN, Napoli) EMMA Meeting (Vienna, Austria) Hematology Debate 2016 (Vienna, Austria)
35
12-13 MARCH 2015
10-11 APRIL 2015
29 APRIL – 2 MAY 2015
6 MAY 2015
18 MAY 2015
6-7 JUNE 2015
11-14 JUNE 2015
23-26 SEPTEMBER 2015
4-7 OCTOBER 2015
2-3-4 NOVEMBER 2015
5-8 DECEMBER 2015
25 JANUARY 2016
29-30 JANUARY 2016
18-19 FEBRUARY 2016
4-5 MARZO 2016
8 MARZO 2016
14-15 MARCH 2016
6 APRIL 2016
23 APRIL 2016
26-27 APRIL 2016
7-8 MAY 2016
Winner of Progressi in Ematologia – I giovani come protagonisti - SIE Giovani (Stazione Marittima, Napoli) Linfoma di Hodgkin e Mieloma: cosa c’è di nuovo (Lecce) Stage biologico-clinico sul mieloma multiplo: dal laboratorio alla terapia (Bologna) Carfilzomib Advisory Board (Zurich, Switzerland) Corso teorico-pratico PICC (AOU Federico II – Napoli) Comunicare2 – LMC – Le Parole che curano (DynamoCamp, Limestre, Pistoia) MyKe Myeloma Knowledge Exchange (Berlin, Germany) Partecipazione con Borsa di studio residenziale al 15° Corso di Formazione avanzata “Infiammazione, cancro e malattie degenerative” (Collegio Ghislieri, Pavia) 21° EHA (Copenaghen, Denmark) MMyCare – Progressi terapeutici nella cura del Mieloma Multiplo (Roma) Relatore presso La gestione delle alterazioni della crasi ematica e delle tossicità da chemioterapia: confronto tra esperti – III Edizione (Hotel Montespina, Napoli) Comfluence – Contributi sulla Mielofibrosi: Link Upgrading e nuovi confronti (Hotel Royal, Napoli) European Iron Academy (Berlin, Germany) Relatore presso Training a field force – Riunione di ciclo AMGEN (Fortevillage - Santa Margherita di Pula (Cagliari)) La malattia di Gaucher meeting (Genova) XIV Congresso Nazionale SIES (Palacongressi Rimini) (Travel Grant) Carfilzomib Advisory Board (Zurich, Switzerland) Il futuro è di chi lo immagina – Carfilzomib Summit (Milano) Nuovo cinema ematologia (Alexander Museum Palace Hotel, Pesaro) Grandangolo in Ematologia. VII Edizione (Milano) Open questions in Hematology 2016
36
17-20 MAY 2016
9-12 JUNE 2016
15-16 JUNE 2016
16 JUNE 2016
28 JUNE 2016
12-13 SEPTEMBER 2016
15 SEPTEMBER 2016
11 OCTOBER 2016
19-21 OCTOBER 2016
2 NOVEMBER 2016
4-5 NOVEMBER 2016
7-8-9 NOVEMBER 2016
14-15 NOVEMBER 2016
19 NOVEMBER 2016
21 NOVEMBER 2016
21-22 NOVEMBER 2016
25-26 NOVEMBER 2016
1-6 DECEMBER 2016
20 JANUARY 2017
27-28 JANUARY 2017
15-17 FEBRUARY 2017
La nuova era degli anticorpi monoclonali nel trattamento del Mieloma Multiplo – Advisory Board (Hotel Royal Continental, Napoli) HEMAexcellence (Bologna) I-O in ematologia (Milano) 58th American Society of Hematology - ASH Annual Meeting and Exposition (San Diego, USA) La nuova sfida dell’infettivologia: la antimicrobial stewardship (Aula magna biotecnologie, Napoli) 15th European Multiple Myeloma Academy (Vienna, Austria) HME Hematology Debate (Rome, Italy) Hematology 2017 – La medicina di precisione del future (Milan, Italy) Highlights from IMW (Bologna, Italy) CoMy – Multiple Myeloma 2017 highlights – A post IMW summary (Paris – France) Stage 2.0 - Nuove prospettive nella leukemia acuta linfoblastica e nel Mieloma Multiplo (Bologna) Relatore presso Il Mieloma Multiplo (Hotel Royal – Napoli) Carfilzomib Advisory Board (Hilton Wien, Austria) Hematology: from clinical studies to bedside (Villa Donnanna – Napoli) Novità in ematologia: la comunicazione, le terapie innovative e di supporto, la sostenibilità (Modena, Italy) A closer look at immune-oncology in Multiple Myeloma (Mostra d’Oltremare – Napoli) Tavola Rotonda “Il valore dell’immuno-oncologia nel Mieloma Multiplo” - BMS (Policlinico AOU Federico II – Napoli) La gestione delle alterazioni della crasi ematica e delle tossicità da chemioterapia: confronto tra esperti – IV Edizione (Centro Congressi Hotel Malaspina – Napoli) 22th EHA – Madrid, Spain (with Oral Comunication and Travel Grant)
37
3-4 MARCH 2017
11-12 APRIL 2017
21-22 APRIL 2017
26-27 APRIL 2017
5 MAY 2017
11 MAY 2017
12-13 MAY 2017
18-19 MAY 2017
26-27 MAY 2017
6 JUNE 2017
15 JUNE 2017
22-25 JUNE 2017
30 JUNE 2017
13-16 SEPTEMBER 2017
30 SEPTEMBER 2017
2-3 OCTOBER 2017
10-11 OCTOBER 2017
15-18 OCTOBER 2017
Le target therapy: management del paziente con Leucemia Linfatica Cronica (LLC) e sostenibilità dei costi SOHO 2017 Annual Meeting, Houston, Texas, USA Il mieloma multiplo: dalla prima linea alla recidiva (Hotel Esedra, Napoli) Focus on Multiple Myeloma (Prof.ssa MV Mateos, Hematology Department – Hospital Universitario de Salamanca, Spain) Corso Rising Medical Stars – Programma di Alta Formazione, with Travel Grant (Sede Springer, Milano) SIE 2017 (Italian Society Hematology, Roma, Italy) with Oral Comunication MM Journey (Palazzo Alabardieri – Napoli) Relatore in L’ematologia, l’oncologia e la medicina del dolore tra umanizzazione delle cure e precision medicine “Leucemia Mieloide Cronica – l’ingresso in clinica dei generic: opportunità e preoccupazioni” (Sala Convegni Croce Rossa Italiana – Napoli) Grandangolo in Ematologia (Milano) Aggiornamenti in Oncologia Pediatrica (Firenze) Fundamental on Gaucher Disease (NH Vittorio Veneto – Roma) Relatore e Responsabile Scientifico in Nuovi scenari in Ematologia (Hotel Esedra – Napoli) “L’approccio terapeutico nel Mieloma Multiplo” 59th American Society of Hematology - ASH Annual Meeting and Exposition (Atlanta, USA) Linfomi e farmaci biosimilari (Hotel Terminus – Napoli) 17th EMMA (European Multiple Myeloma Academy) (Vienna) Hematology Debate (Roma) Post-Atlanta 2017 (Milano) Carfilzomib Advisory Board (Zurich, Switzerland) Progressi in Ematologia – I giovani come protagonisti 1st European Myeloma Network Meeting (EMN) (Torino)
38
9 NOVEMBER 2017
10 NOVEMBER 2017
20-21 NOVEMBER 2017
22 NOVEMBER 2017
24 NOVEMBER 2017
1 DECEMBER 2017
8-12 DECEMBER 2017
19 DECEMBER 2017
19-20 JANUARY 2018
7-9 FEBRUARY 2018
8-9 FEBRUARY 2018
15 FEBRUARY 2018
23-24 MARCH 2018
19-21 APRIL 2018
27-28 APRIL 2018
7-9 MAY 2018
11 MAY 2018
23-25 MAY 2018
6 JUNE 2018
14-17 JUNE 2018
21-22 JUNE 2018
3rd MyKE – Myeloma Experience (Vienna) T-cell Lymphomas: we are close to the finalization (Bologna) Sandoz – Power from Experience (Bologna) Partecipazione con Borsa di studio residenziale al 17° Corso di Formazione avanzata “Epigenetica: dall’ereditarietà transgenerazionale alla malattia” (Collegio Ghislieri, Pavia) Le infezioni fungine invasive in ematologia (Ancona) 23th EHA – Stockholm, Sweden Emapolis (Unicredit Pavilion, Milano) Progetto formative SIE 2018-2019 - Le nuove immunoterapie in ematologia (Hilton Hotel, Milano) Relatore “Lenalidomide in Mantle Cell Lymphoma Patients and MRD status” in “MRD: clinical impact in hematological maligancies” – IRST IRCCS Meldola (FC) I part Training Ixazomib in Multiple Myeloma – Takeda Italia – Starhotel Bologna Percoso JACIE – Raccolta e criopreservazione CSE e interfaccia tra le realtà di Area Vasta, Meldola (FC) Basic Life Support Defibrillation (BLSD) – Forlimpopoli Conosci e scopri le biobanche, Meldola (FC) New Drugs in Hematology (Hotel Carlton, Bologna) Percoso JACIE – Percorso e controllo delle infezioni nel paziente sottoposto ad un autotrapianto di CSE II part Training Ixazomib in Multiple Myeloma – Takeda Italia – Starhotel Bologna Progetto MYTOS (Multiple Myeloma Team Orientation and Experience Sharing) – Hotel Carlton – Bologna La gestione del paziente ricoverato presso la UO di Degenza Oncologica IRST in trattamento dialitico acut Moderatore Sessione “Registry, big data and interpretation” in “Nuove frontiere del NGS nella diagnostica ematologica” Myelodysplastic syndromes: chaos and order, Meldola (FC)
39
5 JULY 2018
7 SEPTEMBER 2018
12 SEPTEMBER 2018
18 SEPTEMBER 2018
20 SEPTEMBER 2018
24 SEPTEMBER 2018
1-3 OCTOBER 2018
9 OCTOBER 2018
10 OCTOBER 2018
15 OCTOBER 2018
16 OCTOBER 2018
24-25 OCTOBER 2018
26 OCTOBER 2018
26 OCTOBER 2018
29 OCTOBER 2018
31 OCTOBER 2018
3 NOVEMBER 2018
Relatore “IMIDs e la modulazione del microambiente nel Mieloma Multiplo: le nuove indicazioni della Lenalidomide e nuove opportunità della Polmalidomide” in “L’ematologia, l’Oncologia e la medicina del dolore tra umanizzazione delle cure e precision medicine” – Sala Convegni Croce Rossa Italiana – Napoli I dati dei Registri Tumori e il loro utilizzo, Meldola (FC) Precision medicine nel trattamento nei tumori urologici, Meldola (FC) Progetto Zoè “Mieloma Multiplo Recidivato refrattario – Experience sharing in real life” – La Borgheriana – Roma Grandangolo in Ematologia – IX Edizione – Hotel Michelangelo – Milano Percoso JACIE – Gestione delle complicanze nel paziente sottoposto ad autotrapianto di CSE Corso Salute e Sicurezza dei lavoratori in sanità – IRST IRCCS - Meldola (FC) Responsabile scientifico del Master in Ematologia Pediatrica 2018/2019– A.O.R.N. Santobono-Pausilipon – Napoli Post ASCO-ESMO – IRST IRCCS - Meldola (FC) 60th American Society of Hematology - ASH Annual Meeting and Exposition (San Diego, USA)
40
6-7 NOVEMBER 2018
13 NOVEMBER 2018
19-21 NOVEMBER 2018
24 NOVEMBER 2018
20 NOVEMBER 2018
1-4 DECEMBER 2018
In compliance with the Italian Legislative Decree no. 196 dated 30/06/2003, I hereby authorize you to use and process my personal details contained in this document
Claudio Cerchione, MD, PhD
